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Abstract
Despite technological advances in public health informatics, the evaluation of infectious
disease surveillance systems data remains incomplete. In this study, a thorough
evaluation was performed of the West Virginia Electronic Disease Surveillance System
(WVEDSS, 2007-2010) and the West Virginia Electronic Disease Surveillance System –
NationalEDSS -Based System (WVEDSS-NBS; March 2012 - March 2014) for Category
II infectious diseases in West Virginia. The purpose was to identify key areas in the
surveillance system process—from disease diagnosis to disease prevention—that need
improvement. Grounded in the diffusion of innovation theory, a quasi-experimental,
interrupted, time-series design was used to evaluate the 2 data sets. Research questions
examined differences in mean reporting time, the 24-hour standard, and comparison of
complete fields (DOB, gender etc.) of the data sets using independent samples t tests. The
study found (a) that the mean reporting times were shorter for WVEDSS compared to
WVEDSS-NBS (p < .05) for all vaccine-preventable infectious diseases (VPID) in
Category II except for mumps; (b) that the 24-hour standard was not met for WVEDSS
compared to WVEDSS-NBS (p < .05) for all VPID in Category II except for mumps, and
(c) that most fields were complete for WVEDSS compared to WVEDSS-NBS (p < .05)
for all VPID in Category II except for meningococcal disease. Healthcare professionals in
the state can use the results of this research to improve the system attributes of timeliness
and completeness. Implications for positive social change included improved access to
public health data to better understand health disparities, which, in turn could reduce
morbidity and mortality within the population.
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Chapter 1: Introduction to the Study
Introduction
There is an increased need for state infectious disease surveillance systems
(IDSS) to be integrated with the National Electronic Disease Surveillance System
(NEDSS) and for )the creation of a national electronic health record (EHR) system. Title
64, Legislative Rule of the West Virginia State Legislature requires health professionals
to report communicable diseases to their local health department. Prior to March 2012,
practitioners, hospitals, providers, and laboratories reported infectious diseases to the
West Virginia Electronic Disease Surveillance System (WVEDSS) by mail or fax. The
Centers for Disease Control and Prevention (CDC) developed a new system model to
interface with National Electronic Disease Surveillance System (NEDSS) and EHR. The
West Virginia Electronic Disease Surveillance System –NationalEDSS Based
Surveillance (WVEDSS-NBS, Department of Health and Human Resources [DHHR],
2011) went live in March 2012. Since then, local health departments have required health
professionals to report infectious diseases via the newly developed WVEDSS-NBS. The
WVEDSS-NBS, is an electronic disease reporting system for West Virginia hospitals,
state public health departments, health professionals, laboratories, and local public health
departments.
The newly developed WVEDSS-NBS, now on a Web-based server, was
established to improve the efficiency and accuracy of infectious disease reporting.
According to Doyle, Glynn, and Groseclose (2002), evaluations of electronic disease
surveillance systems are insufficient, imperfect, and incomplete. Baker (2010) stated that
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reviews at the state level organize and identify improvements that can be applied at the
national level. In this study, I evaluated the old WVEDSS (during the period 2007-2010)
and the newly developed WVEDSS-NBS (from March 2012 to March 2014) to compare
and identify system attributes (specifically timeliness and completeness). The results of
these data are expected to give public health officials the information they need to make
informed decisions about disease outbreaks.
Public health officials rely on the timeliness and completeness of the surveillance
system data reported by the WVEDSS-NBS to design public policies and interventions.
According to Baker, Easther, and Wilson (2010) and the World Health Organization’s
(WHO) International Health Regulations (IHR, 2005), the timeliness of infectious disease
reporting is an essential component of any evaluation where early intervention is a factor.
For Category II infectious diseases, healthcare practitioners and public health
professionals in West Virginia use this research to improve timely reporting, prevention,
and interventions. Doyle et al. (2002) defined infectious disease mandatory reporting as
the routine gathering of individual cases to organize timely prevention and interventions
to control infectious disease outbreaks (p. 1). With accurate and timely reporting, public
health officials have the data needed to plan, organize, and implement public health
interventions and policies to prevent and control infectious disease outbreaks in West
Virginia. In this study, I examined the WVEDSS-NBS for sustainability; I compared
system attributes using the diffusion of innovation theory as a way to understand the
scope of the technological innovation, WVEDSS-NBS.
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Background
In a breakthrough 1988 report, the Institute of Medicine (IOM) identified the core
functions of public health as assessment, policy development, and assurance. Public
health surveillance falls under the assessment function, which consists of collection of
surveillance information, management or assembly of surveillance information into data,
analysis of the data, data interpretation, dissemination, and stimulation. According to
Thacker, Qualters, and Lee (2012), public health surveillance is the foundation of
practice in public health and a vital component of the assessment function. A survey was
conducted by the CDC to establish a baseline for the growth of public health surveillance
at the agency. Of the 434 individuals who responded to the 2009 Web-based survey,
nearly 60% stated that surveillance at the CDC is sound; only 33% stated that the CDC
examines and publishes surveillance data in a timely manner, and only 20% agreed that
the CDC surveillance systems are adaptable and malleable to the mutable environment of
health informatics in the 21st century. The CDC outlined six factors to advance public
health surveillance in the 21st century (Thacker et al., 2012):
§

A shared lexicon of terms needs to be developed.

§

Surveillance needs around the world need to be identified.

§

Informatics concerns and emerging information technologies need to be
maintained,

§

A competent workforce needs to be trained.

§

The analytical concerns of data use and access need to be addressed.

§

The management, storage, and analysis of data must be organized.
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All of these factors are discussed here and applied throughout the study by integration
with the research variables.
Lexicon
From surveys, research, and interviews, the CDC developed six factors to advance
public health surveillance in the 21st century. The principal factor is the lexicon that
health professionals use in their day-to-day working environments. Many medical terms,
acronyms, data-source terms, surveillance system modifiers, types of surveillance
systems, and emerging terms will need to be addressed to design and maintain a national
system to interact at the local and state levels to integrate the gathered information at the
international level. Thacker, Qualters, and Lee (2012) emphasized the need for increased
health situation awareness (Appendix C) and a working knowledge of the theoretical
flowchart of public health surveillance (Appendix D). All states in the U. S. have laws
that identify reportable infectious diseases that must be reported to the state. However,
the CDC has established notifiable infectious diseases that must be reported to the CDC,
these notifiable infectious diseases may or may not be reportable to the state. In order to
address this variance, the CDC and the Council for State and Territorial Epidemiologists
(CSTE) published a report outlining specific requirements for case definitions in 1990
with an update in 1997. The list contains past, current, and future notifiable conditions
that have been validated by the Association of Public Health Laboratories (APHL) for
use in public health practice and surveillance. All states are currently using a shared
lexicon when they use the standard CDC case definitions.
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Global Surveillance Needs
The emergence of new deadly viruses, mutating strains of influenza, and the rise
of bioterrorism in the last few decades of the 20th century has increased the awareness of
global public health issues. The WHO orchestrates global public health surveillance
(much like the CDC organizes the public health concerns within the United States). Each
country is responsible for monitoring diseases and organizing a response, but the IHR
2005 is the only mandatory international contract on disease control. The IHR constitute
an international legal mechanism to incorporate the global public health concerns of 194
countries, including the Member States of WHO. The IHR was revised in 2005 to include
more diseases and to extend the regulations to other areas of international public health
concern. IHR 2005 took effect in June 2007 and requires countries to report infectious
diseases and other public health events of concern to WHO by disregarding border
disputes and focusing on the source, control, and prevention of the disease. The IHR
2005 defined the responsibilities of member countries and the WHO for public health
security and surveillance to strengthen their capacity for public health surveillance and
response at the source of the outbreak. The CDC has been called on to provide technical
assistance and emphasize important IHR 2005 surveillance requirements at world
meetings and summits. According to St. Louis (2012), the CDC proposed a vision for
global public health to incorporate national surveillance systems into a world surveillance
network. An essential step in this process is creating a shared lexicon for a global
network of public health and health professionals. To create a social network so that they
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can communicate among one another and share surveillance data to target disease
outbreaks in a timely manner.
Informatics
Public health informatics is part of a larger field called biomedical or health
informatics; they both require a thorough knowledge and understanding of the integration
of technology, information science, and computer science with respect to public health
and biomedicine. Public health surveillance has used advances and created new
technologies in informatics to investigate and solve public health problems. Savel and
Foldy (2012) identified three public health informatics work areas: the investigation and
explanation of multifaceted systems, the recognition of prospects to enhance the efficacy
and competence of public health systems through inventive data compilation or the
application of data, and the application and upkeep of procedures and systems to
accomplish these enhancements. The evolving field of surveillance informatics must find
innovative ways to incorporate numerous sources of intricate statistics into significant
intelligence that enables officials to implement interventions (Savel and Foldy, 2012).
The investigation, explanation, and integration of multifaceted systems began in
1951 (Appendix E) when the National Office of Vital Statistics began receiving state data
by phone and mail. In 1961, the CDC took over and began publishing the Morbidity and
Mortality Weekly Report (MMWR) with communicable disease information and
statistics. In 1985, the CDC launched the Electronic Surveillance Project (ESP), a
national 5-year project. States are charged with developing their own systems while the
CDC is charged with developing ways to integrate the state data. Thus, the electronic era
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of public health commenced over 25 years ago. The National Notifiable Diseases
Surveillance System (NNDSS) includes all aspects of disease surveillance from the local
to national level. The NNDSS developed the National Electronic Telecommunications
System for Surveillance (NETSS) in 1990 to incorporate state and national records.
NETSS was a DOS-based system and in 1995 the Epidemiology Program Office (EPO)
suggested that an update to NETSS, a Windows-based system. In 1998 an integration
project was started but stopped in 1999 when the CDC Office of the Director’s
Information Resource Management Office created NEDSS.
NEDSS was developed to incorporate local, state, and national electronic
surveillance systems and simplify the transfer of electronic data. The EPO and NETSS
are still the primary sources of surveillance in 2012. In 2000 the CDC provided states
with funding through the Epidemiology Laboratory Capacity (ELC) cooperative
agreement and the CDC developed the NEDSS Base System (NBS), a platform for states
to begin electronic surveillance by utilizing detailed disease modules. In 2004, the CDC
created the Public Health Information Network (PHIN) to broaden the scope of NEDSS
surveillance and the EPO moved to the new Division of Public Health Informatics. The
next year, 27 health departments entered data using the Internet-based systems and 26
jurisdictions received lab results via electronic laboratory reporting (ELR). In 2008, the
CDC and NNDSS received the first Health Level Seven (HL7) messages for disease case
notifications. The HL7 was developed to incorporate clinical and laboratory data into
NEDSS. The CDC reorganized in 2009 by establishing the Office of Surveillance,
Epidemiology, and Laboratory Services. As of 2011, every state used NEDSS-compliant
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surveillance systems and one-third used the NBS. Currently, the CDC receives case
notifications from 57 jurisdictions. One of these jurisdictions is the state of West
Virginia. The WVEDSS was established in 2007 and in March 2012 was converted to the
WVEDSS-NBS.
Skilled Workforce
In order to keep up with the challenges of national and international public health
surveillance, the initial education of new recruits, training, and continuing education of
the growing surveillance workforce is a necessity. According to Drehobl, Roush, Stover,
and Koo (2012), the education of the workforce has not kept up with the expansion of
public health in the 21st century. The American Recovery and Reinvestment Act (ARRA)
of 2009 and the 2010 Patient Protection and Affordable Care Act (ACA) provided
opportunities for the country to increase and educate the public health workforce. The
ARRA provided $50 million to offset budget cuts in state and local public health
departments and the ACA has the initiative to increase the public health workforce and
expand grants to public health surveillance related activities. A sufficient, cultivated, well
informed, and competent health workforce that is prepared to use the appropriate tools is
fundamental for a successful public health surveillance system.
Data Access and Usage
A public health grid (see Appendix F) was used to illustrate the complex nature of
data access and usage within surveillance systems. The grid contains five main hubs
consisting of public health departments, providers, consumers, federal agencies, and
health information exchange. Within this network, information can be shared securely
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and privately. Thacker, Qualters, and Lee (2012) indicated that 77% of the CDC’s survey
respondents replied that a more timely system of information sharing is required for
future development. The grid provides access points and the interrelationship between
hubs in the public health network.
Data Management, Storage, and Analysis
Examining the scientific evidence and applying this knowledge to infectious
disease epidemiology establishes the foundation of effective disease control. In this day
and time, this evidence must be extracted and translated from mountains of data.
Surveillance is the process of collecting, organizing, and analyzing this data to make
health care decisions. Rolka, Walker, English, Katzoff, Scogin, and Neuhaus (2012)
stated that to achieve surveillance goals, an analytical process must be followed, the
process requires hardware and software design, programming, statistical analysis, topic
proficiency, creating models, and successful communication. The ability to translate pure
data sets into epidemiological facts about diseases to policy makers is imperative for
successful surveillance systems.
Purpose of the Study
The purpose of this study was to identify key areas in the process, from disease
diagnosis, to disease prevention in order to improve the surveillance system. A major
limitation among the variables was the reporting behavior of the patients and identifying
where in the reporting process this behavior should occur. This clearly indicated an
opportunity for public health officials to develop education and awareness programs in
this area. Yoo, Park, Park, Lee, Jeong, Lee, & Cho (2009) stated that the most frequent
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measures that affect disease reporting are disease onset, going to the physician, and
recording the diagnosis. Yoo et al. further stated that WHO has issued extensive
guidelines on the evaluation and examination of the steps in the surveillance process.
Healthcare practitioners and public health professionals in the state use this data to
improve the system attributes of timeliness and completeness. The difference between
mean reporting times and the 24-hour standard between the two data sets was evaluated
for timeliness. The required fields were assessed for completeness. Nicolay, Garvey,
Delappe, Cormican, and McKeown (2010) stated that the completeness of the essential
fields on intake forms could affect the sensitivity—and therefore the efficiency—of the
system.
Problem Statement
The problem addressed in this study was the incomplete evaluation of the
reporting of infectious disease surveillance systems data. Doyle et al. (2002) conducted a
quantitative study to determine disease completeness in the United States. They found
that the completeness of infectious disease reporting was related to the disease being
reported. Doyle et al. clarified that underreporting by health professionals and
laboratories may be related to deficits in knowledge of the legal requirement to report,
what diseases to report, how to report diseases, and the consequences of not reporting. To
address this problem, the WVEDSS and the WVEDSS-NBS system attributes (timeliness
and completeness) were compared, and the results evaluated, to recognize and make
improvements in the monitoring and evaluation process. The scope of the system, system
attributes, and existing flaws were examined in order to clarify and address the social,
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structural, technological, and environmental atmosphere that include the complexities of
technological innovations, such as electronic infectious disease surveillance systems and
electronic health records. This study used the system attributes of timeliness and
completeness to identify areas in need of improvement.
To examine the gap of incomplete evaluation of the reporting of infectious disease
surveillance system data, WVEDSS was divided into separate levels in order to ascertain
at what level problems, errors, and nonconformity arose. Nicolay et al. (2010) suggested
that an evaluation of surveillance systems data should include timeliness, completeness,
sensitivity, positive predictive value, and case definitions. Greenhalgh et al. (2008) stated
that shared electronic records are multifaceted systems and all stakeholders and their
practices must accept improvements before the system can run smoothly and efficiently.
Rogers (1995) stated that the diffusion of innovation model encompasses these levels and
further subdivides them into specific definitions and organizational elements. Electronic
disease surveillance systems are intricate innovations that must be accepted, adopted, and
integrated into the daily workload of all participants in the organization. Greenhalgh et al.
(2008) illustrated that the more complex the technology behind an innovation, the greater
the chances of its failure. The importance of this study was that it identified key areas in
the process, from disease diagnosis to disease prevention, in order to pinpoint steps in the
process where data may be missing.
If communicable diseases are consistently being missed, then a different method
for collection of this data is essential for infectious disease prevention and response to
outbreaks. The key variables in this study (timeliness and completeness) were essential to
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identifying the basic structural problems in disease reporting. According to Baker et al.
(2010), evaluating surveillance systems has the added benefit of locating gaps or areas
where information is lost in the system. A clear definition of the steps in the process of
infectious disease surveillance is the primary action in improving the overall performance
of the system. Thacker, Berkelman, and Stroup (1989) suggested that the best way to
accomplish this task is to list the uses of the system and then translate those into goals.
Baker et al. (2010) listed the definition of public health surveillance as “the ongoing
systematic collection, analysis, interpretation and dissemination of data regarding a
health-related event for use in public health action to reduce morbidity and to improve
health” (p. 2). Essential to the elimination and control of infectious diseases in West
Virginia and the United States are the timely reporting of diseases, and complete accurate
data (Averhoff et al., 2006). The objective of this study was to examine these system
attributes to ensure that accurate and timely data are being collected for the system.
The objective of this study after examination was complete was to establish
baseline standards for disease comparison across state lines in the United States and to
establish current levels of infectious diseases within West Virginia. Averhoff et al.
(2006) evaluated the U.S. level of proficiency in detecting endemic rubella transmission
and that rubella might have been eliminated in America. They stated that rubella
detection in the United States is sensitive but that there are no standards to compare this
data across the country. Evaluating the system attributes of timeliness and completeness
identified missing data essential for the local health department to make policy decisions.
The study was based on the following three objectives:
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1. To use the two data sets to calculate the mean reporting time and identify
differences among Category II infectious diseases in West Virginia.
2. To use the two data sets to determine the time difference above or below the
24-hour standard of the Category II infectious diseases in West Virginia.
3. To examine the intake forms on a case-by-case basis for the required fields
(identifier, dob, gender, state, county, identifier for reporting facility, program
area, jurisdiction, date received by public health, specimen source, date
specimen collected, resulted test, organism, add test result button) of the two
data sets to determine the baseline for reporting completeness for Category II
infectious diseases in West Virginia.
Research Questions
This study examined the following three research questions.
1. Is there a difference in mean reporting time of Category II reportable
infectious diseases between the two data systems (WVEDSS & WVEDSSNBS) in West Virginia?
H01 - There is no difference in mean reporting time of Category II infectious
diseases between WVEDSS and WVEDSS-NBS.
Hₐ1 - There is a difference in mean reporting time of Category II infectious
diseases between WVEDSS and WVEDSS-NBS.
2. Is there a difference from the 24-hour standard (time delay) of the infectious
diseases under Category II of the West Virginia reportable infectious diseases
for both data sources?
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H02 - There is no difference from the 24-hour standard for one or both data
sources.
Hₐ2 - There is a difference from the 24-hour standard for one or both data
sources.
3. Are the required fields (Identifier, DOB, Current Sex, State, County,
Reporting Facility Identifier, Program Area, Jurisdiction, Date Received by
Public Health, Specimen Source, Date Specimen Collected, Resulted Test,
Organism, Add Test Result Button) complete for both data sources?
H03 - There is no difference in completeness of the required fields for one or
both data sets.
Hₐ3 - There is a difference in completeness of the required fields for one or
both data sets.
Theoretical Framework for the Study
The diffusion of innovation theory was used to describe the scope of the study and
to establish the foundation for the dissemination of the WVEDSS-NBS. Everett Rogers
developed the diffusion of innovation theory several decades ago and it provides a
“hypothetical scenario of what usually happens when information is spread into a
population” (Bauman, Nelson, Pratt, Matsudo, and Schoeppe’s, 2006, p. 57). Healthcare
surveillance systems are multifaceted and encompass managerial, technical, privacy, and
security aspects that must be processed, adopted, and mastered by individuals and groups
within the system.
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To address innovation in the surveillance system, several essential components of
WVEDSS-NBS structure were examined and evaluated using the diffusion of innovation
theory. These data was used to establish baselines to assess WVEDSS’s timeliness and
completeness. The theory matched this research because it provided the examiner with
the capacity to look at the surveillance system as a whole and the ability to examine
system attributes on a case-by-case basis. An organization may be prepared for
innovation overall but still unequipped for a specific innovation, especially a
technologically based innovation. Rogers (1995) understood that an organization must
achieve a state of system coherence to accept or reject the innovation. A prospective
innovation that is successfully embraced in an organization will have the following
attributes: apprehension for the transformation process, the ability of the innovation to
incorporate into the existing scheme, and evaluation of the consequences of
implementing the innovation. An organization must be prepared at all respective levels in
order for the innovation to be successfully incorporated and maintained. The theoretical
foundation will be discussed in more detail in Chapter 2.
Nature of the Study
This study used quantitative methods to perform a comparative study of the
infectious disease reports that were manually entered into WVEDSS between 2007 and
2010 to the infectious disease reports reported by Web-based server on the newly
developed WVEDSS-NBS, which was established from March 2012 to March 2014. The
research design was a quasi-experimental, interrupted time-series design with nonrandom assignment of groups. Timeliness was assessed by the difference in mean
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reporting times and the 24-hour standard reporting time, using the two independent
samples t tests. The required fields (Identifier, DOB, Current Sex, State, County,
Identifier for Reporting Facility, Program Area, Jurisdiction, Date Received by Public
Health, Specimen Source, Date Specimen Collected, Resulted Test, Organism, Add Test
Result Button) were evaluated for completeness using the two independent samples t
tests.
Definitions
Definitions include an example of different infectious diseases specific to
Category II of the West Virginia Reportable Infectious Diseases (Table 1), certain aspects
of the diffusion of innovation theory, timeliness, completeness, sensitivity, and positive
predictive value.
Table 1
Category II Infectious Diseases (WVDHHR, 2014)
Category	
  II	
  
Infectious	
  
Diseases	
  

	
  
	
  

	
  
	
  

	
  
	
  

	
  
	
  

Clinical	
  
Description	
  

Case	
  Definition	
  
Probable	
  

Case	
  Definition	
  
Confirmed	
  

Laboratory	
  
Evidence	
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Detection	
  of	
  H.	
  
Influenza	
  type	
  b	
  
in	
  blood	
  or	
  CSF	
  
or	
  less	
  
commonly	
  joint,	
  
pleura,	
  or	
  
pericardial	
  
fluid.	
  Positive	
  
	
  
antigen	
  test	
  
results	
  from	
  
urine	
  or	
  serum	
  
samples	
  are	
  
unreliable	
  for	
  
diagnosis	
  of	
  H.	
  
influenza	
  
disease.	
  
	
  hepatitis	
  A,	
  
An	
  acute	
  illness	
  
A	
  case	
  that	
  meets	
   Immunoglobuli
hepatitis	
  A	
  is	
  a	
  
acute	
  
with	
  discrete	
  onset	
   the	
  clinical	
  
n	
  M	
  (IgM)	
  
viral	
  illness	
  that	
   of	
  any	
  sign	
  or	
  
definition	
  is	
  
antibody	
  to	
  
results	
  in	
  
symptom	
  
laboratory	
  
hepatitis	
  A	
  
jaundice,	
  fever,	
  
consistent	
  with	
  
confirmed.	
  And	
  is	
   virus	
  
and	
  loss	
  of	
  
acute	
  viral	
  
not	
  known	
  to	
  
	
  (anti-‐HAV)	
  
appetite,	
  nausea,	
   hepatitis	
  (fever,	
  
have	
  chronic	
  
positive.	
  
malaise,	
  and	
  
headache,	
  malaise,	
   hepatitis	
  B.	
  OR	
  
	
  
sometimes	
  
anorexia,	
  nausea,	
  
A	
  case	
  that	
  meets	
   	
  
diarrhea.	
  
vomiting,	
  diarrhea,	
   the	
  clinical	
  case	
  
Affected	
  
and	
  abdominal	
  
definition	
  who	
  
individuals	
  may	
   pain)	
  and	
  either	
  a)	
   has	
  laboratory-‐
have	
  abdominal	
   jaundice	
  or	
  b)	
  
confirmed	
  
pain,	
  an	
  enlarged	
   elevated	
  serum	
  	
  
hepatitis	
  A	
  (i.e.,	
  
liver,	
  dark	
  urine,	
   aminotransferase	
  
household	
  or	
  
and	
  light	
  stool.	
  
(ALT	
  or	
  AST)	
  
sexual	
  contact	
  
The	
  majority	
  of	
  
levels.	
  
with	
  an	
  infected	
  
infected	
  infants	
  
person	
  during	
  
and	
  preschool	
  
the	
  15-‐20	
  days	
  
children	
  have	
  no	
  
before	
  the	
  onset	
  
signs	
  or	
  
of	
  symptoms.	
  
symptoms	
  of	
  the	
  
disease;	
  
however,	
  they	
  
are	
  just	
  as	
  
infectious	
  as	
  
adults.	
  In	
  
contrast	
  to	
  
hepatitis	
  B	
  and	
  C,	
  
fulminant	
  
disease	
  or	
  death	
  
haemophilu
s	
  influenza,	
  
invasive	
  
disease	
  

Invasive	
  disease	
  
may	
  manifest	
  as	
  
pneumonia,	
  
bacteremia,	
  
meningitis,	
  
epiglottitis,	
  
septic	
  arthritis,	
  
cellulitis,	
  or	
  
purulent	
  
pericarditis,	
  less	
  
common	
  are	
  
endocarditis	
  and	
  
osteomyelitis.	
  

Meningitis	
  with	
  
detection	
  of	
  
haemophilus	
  
influenza	
  type	
  b	
  
antigen	
  in	
  
cerebrospinal	
  fluid	
  
(CSF).	
  

Isolation	
  of	
  	
  
haemophilus	
  
influenza	
  from	
  a	
  
normally	
  sterile	
  
body	
  site.	
  

18

hepatitis	
  B,	
  
acute	
  

pertussis	
  

occurs	
  only	
  
rarely,	
  and	
  there	
  
is	
  no	
  carrier	
  
state.	
  Severe	
  
disease	
  is	
  more	
  
likely	
  to	
  occur	
  in	
  
the	
  elderly	
  or	
  in	
  
persons	
  with	
  
underlying	
  liver	
  
disease	
  
(including	
  
hepatitis	
  C);	
  
however,	
  
complete	
  
recovery	
  is	
  the	
  
rule.	
  
An	
  acute	
  illness	
  
with	
  discrete	
  
onset	
  of	
  any	
  sign	
  
or	
  symptom	
  
consistent	
  with	
  
acute	
  viral	
  
hepatitis	
  (fever,	
  
headache,	
  
malaise,	
  
anorexia,	
  nausea,	
  
vomiting,	
  
diarrhea,	
  and	
  
abdominal	
  pain)	
  
and	
  either	
  
a)jaundice	
  or	
  b)	
  
elevated	
  serum	
  
alanine	
  
aminotransferas
e	
  (ALT)	
  levels	
  >	
  
100	
  IU/L	
  
Whooping	
  cough	
  
usually	
  starts	
  
with	
  cold	
  or	
  flu-‐
like	
  symptoms,	
  
such	
  as	
  runny	
  
nose,	
  sneezing,	
  
fever	
  and	
  a	
  mild	
  
cough.	
  These	
  
symptoms	
  can	
  
last	
  up	
  to	
  two	
  
weeks	
  and	
  are	
  

Persons	
  who	
  have	
  
chronic	
  hepatitis	
  
or	
  persons	
  
identified	
  as	
  
HBsAg	
  positive	
  
should	
  not	
  be	
  
reported	
  as	
  having	
  
acute	
  viral	
  
hepatitis	
  unless	
  
they	
  have	
  evidence	
  
of	
  an	
  acute	
  illness	
  
compatible	
  with	
  
viral	
  hepatitis	
  
(with	
  the	
  exception	
  
of	
  perinatal	
  
hepatitis	
  B	
  
infection).	
  

A	
  case	
  that	
  meets	
  
the	
  clinical	
  
definition	
  is	
  
laboratory	
  
confirmed.	
  And	
  is	
  
not	
  known	
  to	
  
have	
  chronic	
  
hepatitis	
  B.	
  

In	
  the	
  absence	
  of	
  a	
  
more	
  likely	
  
diagnosis,	
  a	
  cough	
  
illness	
  lasting	
  >	
  2	
  
weeks,	
  with	
  at	
  
least	
  one	
  of	
  the	
  
following	
  
symptoms:	
  
• Paroxysms	
  of	
  
coughing;	
  or	
  
• Inspiratory	
  

Acute	
  cough	
  
illness	
  of	
  any	
  
duration,	
  with	
  
isolation	
  of	
  B.	
  
pertussis	
  from	
  a	
  
clinical	
  
specimen;	
  
OR	
  
Cough	
  illness	
  
lasting	
  >	
  2	
  
weeks,	
  with	
  at	
  

IgM	
  antibody	
  to	
  
hepatitis	
  B	
  core	
  
antigen	
  (anti-‐
HBc)	
  positive	
  or	
  
hepatitis	
  B	
  
surface	
  antigen	
  
(HbsAg)	
  
positive.	
  	
  
IgM	
  anti-‐HAV	
  
negative	
  (if	
  
done).	
  	
  

	
  

The	
  culture	
  is	
  
the	
  gold	
  
standard	
  for	
  
diagnosis	
  of	
  
bordetella	
  
pertussis.	
  All	
  
suspected	
  cases	
  
of	
  pertussis	
  
should	
  have	
  a	
  
nasopharyngeal	
  
aspirate	
  or	
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followed	
  by	
  
increasingly	
  
severe	
  coughing	
  
spells.	
  Fever,	
  if	
  
present,	
  is	
  
usually	
  mild.	
  The	
  
clinical	
  course	
  is	
  
divided	
  into	
  
three	
  stages:	
  	
  
Catarrhal	
  Stage:	
  
Characterized	
  by	
  
insidious	
  onset	
  
of	
  coryza	
  (runny	
  
nose),	
  sneezing,	
  
low-‐grade	
  fever,	
  
and	
  a	
  mild,	
  
occasional	
  
cough,	
  similar	
  to	
  
the	
  common	
  
cold.	
  The	
  cough	
  
gradually	
  
becomes	
  more	
  
severe,	
  and	
  after	
  
1-‐2	
  weeks,	
  the	
  
second	
  or	
  
paroxysmal	
  
stage,	
  begins.	
  
Patients	
  with	
  
pertussis	
  are	
  
most	
  infectious	
  
from	
  the	
  
beginning	
  of	
  the	
  
catarrhal	
  stage	
  
through	
  the	
  3rd	
  
week	
  after	
  the	
  
onset	
  of	
  
paroxysms.	
  	
  
Paroxysmal	
  
Stage:	
  
Characterized	
  by	
  
bursts,	
  or	
  
paroxysms	
  of	
  
numerous,	
  rapid	
  
coughs,	
  
apparently	
  due	
  
to	
  difficulty	
  
expelling	
  thick	
  

“whoop”;	
  or	
  
Post-‐tussive	
  
vomiting	
  
AND	
  
• Absence	
  of	
  
laboratory	
  
confirmation	
  
• No	
  
epidemiologic	
  
linkage	
  to	
  a	
  
laboratory	
  
confirmed	
  case	
  
of	
  pertussis.	
  

•

least	
  one	
  of	
  the	
  
following	
  
symptoms:	
  
• Paroxysms	
  of	
  
coughing;	
  or	
  
• Inspiratory	
  
“whoop”;	
  or	
  
• Post-‐tussive	
  
vomiting	
  
AND	
  
• Polymerase	
  
chain	
  
reaction	
  
(PCR)	
  
positive	
  for	
  
pertussis;	
  
Illness	
  lasting	
  >2	
  
weeks,	
  with	
  at	
  
least	
  one	
  of	
  the	
  
following	
  
symptoms:	
  
• Paroxysms	
  of	
  
coughing;	
  or	
  
• Inspiratory	
  
“whoop”;	
  or	
  
• Post-‐tussive	
  
vomiting	
  
AND	
  
• Contact	
  with	
  
a	
  laboratory	
  
confirmed	
  
case	
  of	
  
pertussis.	
  

swab	
  obtained	
  
for	
  culture	
  from	
  
the	
  posterior	
  
nasopharynx.	
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mucous	
  from	
  
tracheobronchial	
  
tree.	
  At	
  the	
  end	
  
of	
  the	
  paroxysm,	
  
a	
  long	
  
inspiratory	
  effort	
  
is	
  usually	
  
accompanied	
  by	
  
a	
  characteristic	
  
high-‐pitched	
  
whoop.	
  During	
  
such	
  an	
  attack,	
  
the	
  patient	
  may	
  
become	
  cyanotic	
  
(turn	
  blue).	
  
Vomiting	
  and	
  
exhaustion	
  
commonly	
  
follow	
  the	
  
episode.	
  The	
  
patient	
  usually	
  
appears	
  normal	
  
between	
  attacks.	
  
The	
  paroxysms	
  
can	
  occur	
  more	
  
frequently	
  at	
  
night.	
  	
  
Convalescent	
  
Stage:	
  
Characterized	
  by	
  
gradual	
  
recovery.	
  The	
  
cough	
  becomes	
  
less	
  paroxysmal	
  
and	
  disappears	
  
over	
  2-‐3	
  weeks.	
  
However	
  
paroxysms	
  often	
  
recur	
  with	
  
subsequent	
  viral	
  
respiratory	
  
infections	
  for	
  
many	
  months	
  
after	
  the	
  onset	
  of	
  
pertussis.	
  Older	
  
persons	
  (i.e.,	
  
adolescents	
  and	
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adults),	
  and	
  
those	
  partially	
  
protected	
  by	
  the	
  
vaccine,	
  may	
  
become	
  infected	
  
with	
  B.	
  pertussis,	
  
but	
  usually	
  have	
  
milder	
  disease.	
  
Pertussis	
  in	
  
these	
  persons	
  
may	
  present	
  as	
  a	
  
persistent	
  (<7	
  
days)	
  cough,	
  and	
  
may	
  be	
  
indistinguishable	
  
from	
  other	
  
upper	
  
respiratory	
  
infections.	
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rabies,	
  
Human	
  

The	
  incidence	
  of	
  
animal	
  bites	
  is	
  
considerably	
  
higher	
  among	
  
children,	
  
particularly	
  
those	
  five	
  to	
  nine	
  
years	
  of	
  age	
  4-‐6.	
  
Incidence	
  
decreases	
  as	
  age	
  
increases.	
  
Injuries	
  inflicted	
  
by	
  dogs	
  are	
  most	
  
common	
  (80-‐
90%),	
  with	
  cats	
  
being	
  the	
  next	
  
most	
  common	
  
species	
  
involved3,	
  4.	
  
Doberman	
  
pinschers,	
  
German	
  
shepherds,	
  and	
  
pit	
  bull	
  terriers	
  
are	
  the	
  most	
  
common	
  
purebred	
  
canines	
  
implicated	
  in	
  
fatal	
  attacks.	
  	
  

	
  

Rabies	
  is	
  an	
  
acute	
  
encephalomyeliti
s	
  that	
  almost	
  
always	
  
progresses	
  to	
  
coma	
  or	
  death	
  
within	
  10	
  days	
  
after	
  the	
  first	
  
symptom.	
  Rabies	
  
virus	
  belongs	
  to	
  
the	
  order	
  
mononegavirales
,	
  viruses	
  with	
  
non-‐segmented,	
  
negative-‐

Human	
  Exposure	
  	
  
A	
  bite	
  or	
  scratch	
  
from	
  a	
  vector	
  
species	
  or	
  the	
  
introduction	
  of	
  
saliva	
  or	
  central	
  
nervous	
  system	
  
(CNS)	
  tissue	
  from	
  a	
  
vector	
  species	
  into	
  
an	
  open,	
  fresh	
  
wound	
  or	
  mucous	
  
membrane	
  (	
  eye,	
  
mouth,	
  or	
  nose)	
  of	
  
a	
  human	
  being.	
  	
  

A	
  clinically	
  
•
confirmed	
  case	
  
that	
  is	
  laboratory	
  
confirmed	
  by	
  
testing	
  at	
  a	
  state	
  
or	
  federal	
  public	
  
health	
  
laboratory.	
  

	
  

Vector	
  Species	
  	
  
Species	
  include	
  
bats	
  or	
  terrestrial	
  
mammals,	
  
especially	
  
carnivores.	
  Wild	
  
species	
  known	
  to	
  
be	
  reservoirs	
  of	
  
rabies	
  include,	
  but	
  
are	
  not	
  limited	
  to,	
  
raccoons,	
  skunks,	
  
foxes,	
  coyotes,	
  
bobcats,	
  wolves,	
  or	
  
any	
  hybrids	
  
between	
  these	
  wild	
  
species	
  and	
  
domestic	
  dogs	
  and	
  
cats.	
  	
  
Domestic	
  species	
  
include,	
  but	
  are	
  not	
  
limited	
  to,	
  dogs,	
  
cats,	
  and	
  ferrets.	
  

•

•

•

Detection	
  of	
  
lyssavirus	
  
antigens	
  in	
  
a	
  clinical	
  
specimen	
  
(preferably	
  
the	
  brain	
  or	
  
the	
  nerves	
  
surroundin
g	
  hair	
  
follicles	
  in	
  
the	
  nape	
  of	
  
the	
  neck)	
  by	
  
direct	
  
fluorescent	
  
antibody	
  
test,	
  or	
  
Isolation	
  (in	
  
cell	
  culture	
  
or	
  in	
  
laboratory	
  
animal)	
  of	
  a	
  
lyssavirus	
  
from	
  saliva	
  
or	
  CNS	
  
tissue;	
  or	
  
Identificatio
n	
  of	
  
lyssavirus	
  
specific	
  
antibody	
  
(i.e.	
  by	
  
indirect	
  
fluorescent	
  
antibody	
  
(IFA)	
  test	
  or	
  
complete	
  
rabies	
  virus	
  
neutralizati
on	
  at	
  1:5	
  
dilution)	
  in	
  
the	
  serum	
  
of	
  an	
  
unvaccinate
d	
  person;	
  or	
  
Detection	
  of	
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  rubella	
  

stranded	
  RNA	
  
genomes.	
  Within	
  
this	
  group,	
  
viruses	
  with	
  a	
  
distinct	
  "bullet"	
  
shape	
  are	
  
classified	
  in	
  the	
  
rhabdoviridae	
  
family;	
  which	
  
includes	
  at	
  least	
  
three	
  genera	
  of	
  
animal	
  viruses,	
  
lyssavirus,	
  
ephemerovirus,	
  
and	
  vesiculovirus.	
  
The	
  genus	
  
lyssavirus	
  
includes	
  the	
  
rabies	
  virus10.	
  
Rubella	
  is	
  a	
  viral	
  
illness	
  caused	
  by	
  
a	
  togavirus	
  of	
  the	
  
genus	
  rubivirus	
  
and	
  is	
  
characterized	
  by	
  
a	
  mild,	
  
maculopapular	
  
rash.	
  The	
  rubella	
  
rash	
  occurs	
  in	
  
50%–80%	
  of	
  
rubella-‐infected	
  
persons	
  and	
  is	
  
sometimes	
  
misdiagnosed	
  as	
  
measles	
  or	
  
scarlet	
  fever.	
  
Children	
  usually	
  
develop	
  few	
  or	
  
no	
  constitutional	
  
symptoms,	
  but	
  
adults	
  may	
  
experience	
  a	
  1–
5-‐day	
  prodrome	
  
of	
  low-‐grade	
  
fever,	
  headache,	
  
malaise,	
  mild	
  
coryza,	
  and	
  

lyssavirus	
  
viral	
  RNA	
  
(using	
  
reverse	
  
transcriptas
e-‐
polymerase	
  
chain	
  
reaction	
  
[RT-‐PCR}	
  in	
  
saliva,	
  CSF,	
  
or	
  tissue.	
  

In	
  the	
  absence	
  of	
  a	
  
more	
  likely	
  
diagnosis,	
  an	
  
illness	
  
characterized	
  by	
  
all	
  of	
  the	
  following:	
  
• Acute	
  onset	
  of	
  
generalized	
  
maculopapular	
  
rash;	
  and	
  
• Temp.	
  >	
  99.0⁰F	
  
or	
  37.2⁰C;	
  and	
  
• Arthralgia,	
  
arthritis,	
  
lymphadenopa
thy,	
  or	
  
conjunctivitis;	
  
and	
  
• Lack	
  of	
  
epidemiologic	
  
linkage	
  to	
  a	
  
laboratory-‐
confirmed	
  case	
  
of	
  rubella;	
  and	
  
• Noncontributo
ry	
  or	
  no	
  
serologic	
  or	
  

A	
  case	
  with	
  or	
  
without	
  
symptoms	
  who	
  
has	
  laboratory	
  
evidence	
  of	
  
rubella	
  infection	
  
confirmed	
  by	
  one	
  
or	
  more	
  of	
  the	
  
following	
  
laboratory	
  tests:	
  
• Isolation	
  of	
  
rubella	
  virus;	
  
or	
  
• Detection	
  of	
  
rubella-‐virus	
  
specific	
  
nucleic	
  acid	
  
by	
  
polymerase	
  
chain	
  
reaction;	
  or	
  
• Significant	
  
rise	
  between	
  
acute-‐	
  and	
  
convalescent
-‐phase	
  titers	
  
in	
  serum	
  
rubella	
  

Rubella	
  virus	
  
can	
  be	
  detected	
  
from	
  nasal,	
  
throat,	
  urine,	
  
blood,	
  and	
  
cerebrospinal	
  
fluid	
  specimens	
  
from	
  persons	
  
with	
  rubella.	
  
The	
  best	
  results	
  
come	
  from	
  
throat	
  swabs.	
  
Cerebrospinal	
  
fluid	
  specimens	
  
should	
  be	
  
reserved	
  for	
  
persons	
  with	
  
suspected	
  
rubella	
  
encephalitis.	
  
Efforts	
  should	
  
be	
  made	
  to	
  
obtain	
  clinical	
  
specimens	
  for	
  
virus	
  detection	
  
from	
  all	
  case-‐
patients	
  at	
  the	
  
time	
  of	
  the	
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conjunctivitis.	
  
Postauricular,	
  
occipital	
  and	
  
posterior	
  
cervical	
  
lymphadenopath
y	
  is	
  
characteristic	
  
and	
  precedes	
  the	
  
rash	
  by	
  5–10	
  
days.	
  Arthralgia	
  
or	
  arthritis	
  may	
  
occur	
  in	
  up	
  to	
  
70%	
  of	
  adult	
  
women	
  with	
  
rubella.	
  Rare	
  
complications	
  
include	
  
thrombocytopen
ic	
  purpura	
  and	
  
encephalitis.	
  
Rubella	
  is	
  
transmitted	
  
through	
  direct	
  or	
  
droplet	
  contact	
  
from	
  
nasopharyngeal	
  
secretions	
  and	
  
has	
  an	
  average	
  
incubation	
  
period	
  of	
  17	
  days	
  
(range:	
  12–23	
  
days).	
  Persons	
  
with	
  rubella	
  are	
  
most	
  infectious	
  
when	
  rash	
  is	
  
erupting,	
  but	
  
they	
  can	
  shed	
  
viruses	
  from	
  7	
  
days	
  before	
  to	
  7	
  
days	
  after	
  rash	
  
onset.	
  
When	
  rubella	
  
infection	
  occurs	
  
during	
  
pregnancy,	
  
especially	
  during	
  

virology	
  
testing.	
  

immunoglob
ulin	
  G	
  
antibody	
  
level	
  by	
  any	
  
standard	
  
serologic	
  
assay;	
  or	
  
Positive	
  
serologic	
  test	
  
for	
  rubella	
  
immunoglob
ulin	
  M	
  (IgM)	
  
antibody;	
  

initial	
  
investigation.	
  
Virus	
  may	
  be	
  
detected	
  from	
  1	
  
week	
  before	
  to	
  
2	
  weeks	
  after	
  
rash	
  onset.	
  
However,	
  
•
maximum	
  viral	
  
shedding	
  occurs	
  
up	
  to	
  day	
  4	
  
after	
  rash	
  onset.	
  
Real-‐time	
  RT-‐
PCR	
  and	
  RT-‐
OR	
  
PCR	
  can	
  be	
  
An	
  illness	
  
characterized	
  	
  by	
   used	
  to	
  detect	
  
rubella	
  virus	
  
all	
  of	
  the	
  
and	
  has	
  been	
  
following:	
  
• Acute	
  onset	
   extensively	
  
evaluated	
  for	
  its	
  
of	
  
usefulness	
  in	
  
generalized	
  
maculopapul detecting	
  
rubella	
  virus	
  in	
  
ar	
  rash;	
  and	
  
clinical	
  
• Temp.	
  >	
  
specimens.	
  
99.0⁰F	
  or	
  
Clinical	
  
37.2⁰C;	
  and	
  
specimens	
  
• Arthralgia,	
  
obtained	
  for	
  
arthritis,	
  
virus	
  detection	
  
lymphadeno
and	
  sent	
  to	
  CDC	
  
pathy,	
  or	
  
are	
  routinely	
  
conjunctivitis
screened	
  by	
  
;	
  and	
  
these	
  
• epidemiologi techniques.	
  
c	
  linkage	
  to	
  a	
   Molecular	
  
laboratory-‐
typing	
  is	
  
confirmed	
  
recommended	
  
case	
  of	
  
because	
  it	
  
rubella	
  
provides	
  
important	
  
epidemiologic	
  
information	
  to	
  
track	
  the	
  
epidemiology	
  of	
  
rubella	
  in	
  the	
  
United	
  States	
  
now	
  that	
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the	
  first	
  
trimester,	
  
serious	
  
consequences	
  
can	
  result.	
  These	
  
include	
  
miscarriages,	
  
fetal	
  
deaths/stillbirth
s,	
  and	
  a	
  
constellation	
  of	
  
severe	
  birth	
  
defects	
  known	
  as	
  
congenital	
  
rubella	
  
syndrome	
  (CRS).	
  
The	
  most	
  
common	
  
congenital	
  
defects	
  are	
  
cataracts,	
  heart	
  
defects	
  and	
  
hearing	
  
impairment.	
  

rubella	
  virus	
  no	
  
longer	
  
continuously	
  
circulates	
  in	
  
this	
  country.	
  By	
  
comparing	
  
virus	
  sequences	
  
obtained	
  from	
  
new	
  case-‐
patients	
  with	
  
other	
  virus	
  
sequences,	
  the	
  
origin	
  of	
  
particular	
  virus	
  
types	
  in	
  this	
  
country	
  can	
  be	
  
tracked.	
  
Furthermore,	
  
this	
  information	
  
may	
  help	
  in	
  
documenting	
  
the	
  
maintenance	
  of	
  
the	
  elimination	
  
of	
  endemic	
  
transmission.	
  In	
  
addition,	
  
genotyping	
  
methods	
  are	
  
available	
  to	
  
distinguish	
  
wild-‐type	
  
rubella	
  virus	
  
from	
  vaccine	
  
virus.	
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Definitions
Case Definition: A case definition is set of uniform criteria used to define a
disease for public health surveillance. Case definitions enable public health to classify
and count cases consistently across reporting jurisdictions, and should not be used by
healthcare providers to determine how to meet an individual patient’s health needs.
(CDC, 2013)
Communication: A process in which participants create and share information
with one another in order to reach a mutual understanding. Diffusion is a particular type
of communication in which the message content that is exchanged is concerned with a
new idea. (Rogers, 2003, p. 18)
Communication channel: The means by which messages get from one individual
to another. (Rogers, 2003, p. 18)
Completeness or data quality: Data quality reflects the completeness and validity
of the data recorded in the public health surveillance system. Examining the percentage
of blank "required" responses to items on surveillance forms is a straightforward and easy
measure of data quality. (CDC, 2011, p. 407)
Diffusion: The process in which an innovation is communicated through certain
channels over time among the members of a social system. (Rogers, 2003, p. 11)
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Diffusion of Innovation Theory: The diffusion model is a conceptual paradigm
with relevance for many disciplines. The multidisciplinary nature of diffusion research
cuts across various scientific fields. A diffusion approach provides a common conceptual
ground that bridges these divergent disciplines and methodologies. (Rogers, 2003, p.
103-104)
Dissemination: Diffusion that is directed and managed. (Rogers, 2003, p. 7)
Innovation: An idea, practice, or object perceived as new by an individual or other
unit of adoption. (Rogers, 2003, p. 12)
Positive Predictive Value (PPV): The proportion of persons identified as having
cases that actually do have the condition under surveillance. (CDC, 2011, p. 407)
Sensitivity: The sensitivity of a surveillance system can be considered on two
levels. First, at the level of case reporting, sensitivity refers to the proportion of cases of a
disease (or other health-related event) detected by the surveillance system (43). Second,
sensitivity can refer to the ability to detect outbreaks, including the ability to monitor
changes in the number of cases over time. (CDC, 2011, p. 407)
Social Change: The process by which alteration occurs in the structure and
function of a social system. (Rogers, 2003, p. 6)
Technology: A design for instrumental action that reduces the uncertainty in the
cause-effect relationships involved in achieving a desired outcome. (Rogers, 2003, p. 13)
Time: Time is involved in diffusion in (1) the innovation-diffusion process, (2)
innovativeness, and (3) an innovation’s rate of adoption. (Rogers, 2003, p. 37)
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Timeliness: Timeliness reflects the speed between steps in a public health
surveillance system (CDC, 2011, p. 407)
Uncertainty: The degree to which a number of alternatives are perceived with
respect to the occurrence of an event and the relative probability of these alternatives
(Rogers, 2003, p. 6).
Assumptions
The major assumption was that all data had been reported accurately for both
surveillance systems within the times specified, WVEDSS (2007-2010) and WVEDSSNEDSS (March 2012-March 2014).
Scope and Delimitations
The West Virginia state epidemiology office was contacted for permission to
evaluate all Category II infectious disease data reported within the specified time frame.
Category II infectious diseases were included in the study and not Category I, III, IV, or
V infectious diseases. I worked with the West Virginia state epidemiology office to
determine which cases of Category II infectious diseases in West Virginia to examine to
achieve more power for the analysis. The system attributes of timeliness and
completeness were covered, but not sensitivity and positive predictive value.
The sample size, which included over 1000 cases of infectious disease from the
entire state, increased the reliability of the sample. Lee and Baskerville (2003) explained
that to increase the reliability of a random sample the size of the sample must be
increased. Increasing the sample size reaffirms what has been uncovered in the sample
but does not allow the sample findings to be generalized to the population. Increasing the
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sample size does increase the level of statistical significance and the generalizability of
the sample to other samples, but not to the population being studied or to the rejection or
acceptance of the null hypothesis. This sampling procedure does reduce the likelihood of
a Level I error. The only scientifically acceptable way to generalize a theory in a new
setting is for the theory to persist in an experiential test in that setting.
Limitations
The entire state is required to submit their reportable cases to their local health
departments. The limitation for this study is that secondary data will be collected from
the past from two different time periods. Creswell (2009) stated that limitations in data
not collected for research purposes or data collected in the past are that it can be
incomplete, inaccurate, have selection bias, and many other variables that are unknown to
the researcher. Limitations from using data from two different time periods can be that
cases are not randomized, pre- and post- groups may not have the same characteristics,
others factors may indicate confounding bias (Creswell, 2009). According to Harris,
Bradham, Baumgarten, Zuckerman, Fink, and Perencevich (2004) the nonrandom nature
of a quasi-experimental design is its major weakness. The data in this study will selected
by convenience and will include all data entered for the time periods specified.
Other weaknesses in the study design were regression to the mean and maturation
effects. Regressions to the mean and maturation effects were both threats to internal
validity in this study. Regression to the mean was a possible threat because the
intervention may or may not have been the reason for an improvement in surveillance.
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Maturation effects were a possible threat in concluding that the intervention caused an
improvement in reporting.
A major weakness in regard to the variables was the reporting behavior of the
patients and in identifying where in the reporting process this behavior occurs. The
reporting behavior of the patients is only attributable to the date of disease onset. Since
timeliness was measured from diagnosis date to report date this clears the patients
reporting behavior as a limitation to the study. This clearly indicates an opportunity for
public health officials to develop education and awareness programs.
Social Change Implications
The results of this study may provide health departments with the information and
tools to address the fundamental factors that help public health officials assess the
population’s health. Integration of the EHR with WVEDSS-NBS affords health
professionals instant access to the most recent health data and thus allows local health
departments to effect social change. Positive social change begins with reducing
morbidity and mortality of infectious diseases within the population and this study
identified issues related to timeliness and the completeness of intake forms. Colbert and
Harrison (2011) stated that to accomplish these objectives and to understand the complex
matrix of health disparities, more complete epidemiological and surveillance data must be
acquired. An evaluation of surveillance system data was done on West Virginia to
identify the incidence of Category II infectious diseases and to assess the effectiveness of
the state health department by examining, comparing, and evaluating the old WVEDSS
and the newly developed WVEDSS-NBS for the system attributes of timeliness and
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completeness. I used the diffusion of innovation theory to examine the environment in
which the surveillance systems operated in order to identify areas for improvement and
sustain social change.
Significance
Health practitioners in West Virginia could use the results of this research to
improve the time from reporting of the infectious disease to recording them in the
database. With accurate and timely reporting, public health officials have the necessary
data to plan, organize, and implement public health interventions and policies to prevent
and control infectious disease outbreaks in West Virginia.
1. Improve the timeliness of reporting the Category II infectious diseases in West
Virginia by establishing evidence-based evaluation criteria to identify differences
in mean reporting time.
2. Identify sources of reporting delay from the 24-hour standard within Category II
infectious diseases in West Virginia.
3. Improve the completeness of required fields for both data sets of Category II
infectious diseases of the West Virginia by examining identifier, dob, gender,
state, county, identifier for reporting facility, program area, jurisdiction, date
received by public health, specimen source, date specimen collected, resulted test,
organism, and add test result button.
Summary and Transition
The current WVEDSS-NBS was active as of March 2012 and further
implementation of the system continued throughout 2014. Data from the old system,
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WVEDSS, was not used in the current system because only new data was uploaded. The
goal of the current WVEDSS-NBS is to implement and incorporate infectious disease
data across multiple states surrounding West Virginia and integrate the IDSS with the
electronic health record (EHR). The goal of this study was to compare the system
attributes of timeliness and completeness of the previous WVEDSS to the current
WVEDSS-NBS to ensure the accuracy of surveillance system data.
Chapter 2 will connect the variables of the two data sets to the system attributes of
timeliness and completeness. This study specifically focused on the valuation of
reporting the Category II infectious diseases (Table 1) before and after the Web-based
server was employed in March 2012. Key variables and their relation to the system
attributes were discussed to further the analysis of the two data sets.
Chapter 3 will discuss the research method, a quasi-experimental interrupted
time-series design comparing two data sets before and after a technological intervention.
The evaluation of data is an integral part of surveillance systems access and usage.
Chapter 4 will discuss the time frame for data collection, discrepancies in data collection
from the Chapter 3 plan, baseline descriptive and demographic characteristics of the
sample, challenges to implementation as described in Chapter 3, statistical assumptions,
and results. Chapter 5 will discuss the interpretations, limitations, recommendations, and
implications of these findings.
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Chapter 2: Literature Review
Introduction
Despite technological advances in pubic health informatics, the evaluation of
infectious disease surveillance systems data remains incomplete.. Sickbert-Bennett,
Weber, Poole, MacDonald, and Maillard (2011) stated that the evaluation of infectious
disease surveillance system data is not complete and further measures need to be
undertaken to ensure the reliability of these statistics. According to Baker, Easther, and
Wilson (2010), potential gaps exist within surveillance system data and existing data is
not integrated with the electronic health record. Chriqui, O’Connor, and Chalaoupka
(2011) agreed with Baker et al., writing that there was a need for a consistent review of
surveillance systems, especially in regard to the development of policy and interventions.
Baker et al. (2010) suggested the use of WHO and IHR standards to assess variances in
surveillance system data, to identify improvements at the local level, and to examine all
relevant surveillance system stages across an area of disease burden. Sahal, Reintjes, and
Aro (2009) illustrated the point, writing that the main issue is in the completeness of
reporting surveillance system data. Routine evaluations of surveillance systems are
imperative for infectious disease detection and for ensuring that accurate feedback is
provided to health professionals. Therefore, the purpose of this study was to identify key
sections within the two data sets, (WVEDSS and WVEDSS-NBS), where data may be
absent or lacking so that corrections could be made to the system. This chapter provides
an in-depth examination of issues related to public health surveillance.
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Literature Search Strategy
To identify prospective, peer-reviewed articles and books, the following
databases—PubMed and Medline—were searched for the years 2008 to the present using
the following keywords (with Boolean operators to maximize the results): surveillance
systems, electronic surveillance systems, infectious disease surveillance, WVEDSS,
WVEDSS-NBS, timeliness of surveillance systems, completeness of surveillance systems,
diffusion of innovation theory, sensitivity of surveillance systems, positive predictive
value of surveillance systems. The CDC website was also valuable.
While the review focused on current peer-reviewed articles, it included an
extensive review of theories and seminal literature related to surveillance system policy
and government interactions. The literature review was organized by themes found in the
literature: the problem statement, the diffusion of innovation theory, the quantitative
method for surveillance systems, system attributes of timeliness and completeness, and a
summary.
Theoretical Foundation: Diffusion of Innovation
Source of the Theory
Rogers developed the theory, diffusion of innovation, in 1995 and wrote five
books about the theory over the next 8 years. Rogers (2003) stated that diffusion is more
of a social progression than a mechanical issue. This paper will utilize his first book and
his most recent work of the same title written in 2003 with updates that have occurred in
research and innovations since his first publication. Greenhalgh et al. (2008) illustrated
that the more complex the technology behind an innovation the greater the chances of
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failure of the innovation. Rogers (2003) emphasized that the diffusion of innovation
describes social change as an essential aspect of human development. According to
Greenhalgh et al. (2008), the aspect of diffusion of innovation that deals with the
integration of the social and technological aspects is defined as the socio-technical aspect
of change (p. 9). Healthcare surveillance systems are multifaceted structures that embody
more than the social and technological aspects of surveillance systems. They incorporate
outbreak information, social, technological, managerial, privacy, and security aspects and
all of these must be processed, adapted, and mastered by individuals and groups within
the system.
Major Theoretical Propositions
A technological innovation requires more information to be exchanged within the
system and if done correctly reduces uncertainty among the stakeholders embracing the
innovation. According to Rogers (2003) diffusion of innovation is the progression of
communication exchange throughout a social system that initiates social change within
the system. The organization undergoes alterations in the configuration and purpose of
their social system through the integration of new philosophies and technologies by
change agents. Rogers stated, “the main elements of the diffusion of innovation theory
are innovation, communication, time, and the social system” (p. 861). These elements can
be identified in all studies and programs revolving around the theory.
Technology is a blueprint for implementing a change to reduce the uncertainty
about the advantages and disadvantages of achieving a certain outcome. Two basic
aspects of technology include the hardware (the tool) and the software used as the
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knowledge center for the tool. Rogers (2003) stated that the decision making process uses
information gathering and information reasoning as another means to overcome user
doubts. According to Rogers (2003) researchers need to evaluate all the existing
technologies within a surveillance system as a technology cluster because they are
intimately related. He defined a technology cluster as one or more elements of technology
that are symbiotic and diffuse at the same time in a system (p. 383). Past research focused
on each new technological development as an isolated innovation. Rogers (2003)
identified “rate of adoption (relative advantage and compatibility), complexity,
trialability, and observability as the perceived attributes of innovations” (p. 1346).
Greenhalgh et al. (2004) emphasized these attributes in their work and they can be
identified as diffusion, dissemination, implementation, and sustainability (p. 582). These
attributes have been identified through past research as the most important aspects in
explaining adoption rate.
Literature and Research-Based Analysis
Prior research on the diffusion of innovation theory used specific criteria to
examine the overall evidence supporting their conclusions and discussed thirteen research
areas supporting the theory in health service organizations. Greenhalgh et al. (2004)
traced the chronological growth of the perceptions, the model, and the approaches in
diffusion of innovation by examining the literature and evaluating experts in different
fields, and quantifying this data as narrative. They designed an information-mining tool
to abstract the key aspects of the theory to compare in their narrative using the World
Health Organization Health Evidence Network (WHO-HEN) criteria. Earlier research on
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diffusion of innovation theory was classified under four categories: rural sociology,
medical sociology, communications studies, and marketing studies.
Opinion leaders and change agents influence interventions and communication
within the organization or system. Rogers (2003) developed the area of rural sociology
and he defined innovations as new concepts to farmers and defined diffusion as the
spread of individual ideas mostly by imitation (p. 591). Rogers (2003) illustrated the
importance of social networks specifically how individuals became adopters and how
they make the decision to adopt or reject a technology. The medical sociology model
followed Rogers’s model but applied to doctors, particularly their behaviors when
prescribing new antibiotics. These early studies set a precedent, as their focus was to
define individuals who used social networks as cultured and sophisticated consumers
marking them as the first to embrace new inventions.
Rogers (1995) developed his fundamental concept of diffusion of innovations
through the rural sociological approach using communication studies that focused on
innovations as ‘news’ or information that was spread through the news network of
television, newspapers, or by individuals. Rogers and Kincaid (1981) focused their
communication research in this area focusing on how fast the message was transmitted,
where the message was transmitted, and how the changing critical variables influenced
diffusion. The marketing category studied innovations as if they were products and
developed mathematical models to forecast adoption behavior (Bass, 1969; Boehner &
Gold, 2012). Potvin, Haddad, and Frohlich (2001) identified the qualities and demands of
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innovations, the personalities and behaviors of adopters, and the effect of the magnitude
of media campaigns on adopter’s decisions.
As a result of the limitations identified in the conceptual models several new
research areas were created including: development studies, health promotion, evidencebased medicine, and several areas in the organization and management literature. These
earlier studies had many faulty theoretical suppositions: the individual was all that
mattered, that accepting the new idea was the only decision; adoption can be predicted by
examining the character of the adopters, and that diffusion research is universal
(Greenhalgh et al., 2004). Studies found in the organizational management literature
include research done on structural climate and culture (Damanpour, 1991, 1992, 1996);
studies conducted on the interaction between groups (Abrahamson, 1991; Abrahamson &
Fairchild, 1999); information based approaches to innovations in organizations (Nonaka
& Takeuchi, 1995; Zahra & George, 2002); and organizational psychology (UK
Department of Health, 2001).
The research focusing on innovation covered the structural climate and culture
intertwined with the conventional transformation organization literature. Studies focusing
on organizational process, context, and culture dealt with three main areas of research:
acceptance, integration, and predictable nature of an innovation (Greenhalgh et al., 2004).
This area of research used qualitative methods, mainly ethnographic, focusing on the
human aspect including the overall social environment of the organization emphasizing
culture, power, leadership, and risk taking attitudes (Greenhalgh et al., 2004). Interorganizational studies dealt with the organization innovativeness compared to other
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organizations on concepts that were essential to forming a social network. Studies that
illustrated the connections between organizations focused on networking as a distinct
form of communication within the organizations. The last area of research covered
related to this study was organizational psychology where leadership skills such as
pioneering, evaluation, and working effectively with employees contributed to the
adoption of the innovation.
Rationale for the Diffusion of Innovation Theory
The definition and measurement of the diffusion of innovation theory provided a
framework for the review of the literature in a systematic and methodic fashion.
Greenhalgh et al. (2004) performed a meta-analysis of the literature using a new
technique to answer the following question, how can we spread and sustain innovations
in health service delivery and organization (p. 583)? Greenhalgh et al. (2004) defined
innovation in health care as an innovative set of actions, customs, and operations that
focus on perfecting health outcomes, managerial competence, and budgeting efficiency
through proper planning and synchronized activities. Bunduchi, Weisshaar, and Smart
(2011) stated that the major portion of costs occur in the early stages of a technological
innovation with development, capital, ethical, and implementation costs prevailing.
Greenhalgh et al. (2008) stated that identifying important aspects of the direction, vision,
relationships, and the team in implementing a complex technological innovation begins
with defining the theory of diffusion in innovation. Bunduchi et al. (2011) agreed that the
technological aspect of the innovation is a significant factor and influences the outcomes
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of the entire innovation. Integrating the technological aspect of the surveillance system
into the daily routine of the organization is essential to its success.
Diffusion of innovation theory establishes a predefined framework for the
researcher to build on as the innovation is integrated into the organization. The purpose
was to illustrate the diffusion of innovation theory so that later innovations can be done
more efficiently through the understanding and the development of diffusion and
dissemination. In Bauman et al. (2006) stated that the main focus was to define
dissemination and to reinforce evidence-based practices in public health. Dissemination
was defined as describing the communication method utilized along certain paths by
varying means in order to reach targeted stakeholders (Bauman et al., 2006). Greenhalgh
et al. (2004) described diffusion as a passive process and dissemination as the active
integration of the innovation into the organization. Diffusion occurs through personal
encounters and is more informal and unstructured where dissemination is a formal
planned implementation process that has a predetermined structure and uses social
networks to create awareness and spread a message.
The process of diffusion is first identified as an informal planning process that is
followed by a formal structured procedure driven by social networking within the
organization. Formal dissemination programs are accountable for understanding the
varying viewpoints of adopters, weighing the positive and negatives, identifying
subdivisions of the whole, categorizing their characteristics, clearly constructing a
mission, using the appropriate communication networks; and auditing and appraising
objectives and targets (Greenhalgh et al., 2004). Researchers contesting the paradigms of
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diffusion research have illustrated that those new technologies previously integrated
using only simple diffusion should have gone through a more formal dissemination
process (Greenhalgh et al., 2004). For instance, Rogers (2003) suggested using the
technology cluster model for technological innovations that include more than one
technology within the system. In this way the stakeholders consider all aspects of the
innovation and a coordinated strategy is created for implementation.
How the Diffusion of Innovation Theory Relates to the Present Study
Public health researchers and professionals have campaigned for greater
coordination in traditional public health surveillance actions pursuits. According to
Fedorowicz and Gogan (2010) several surveillance systems have been used to track
infectious diseases using different data collection methods and procedures leading to an
abundance of irreconcilable databases and applications. The uniformity of the theory
developed by Rogers (2003) is needed to examine this technological cluster as a whole,
as the innovation is implemented within local and national networks (Fedorowicz et al.,
2010). The theory has been utilized by Dearing (2009) to potentiate the spread of
evidence-based practice to invoke social change. Bauman et al. (2006) stated that to
create a solid foundation for dissemination efforts more research on diffusion in
healthcare and public health is needed. A standard needs to be established for evaluating
data and communicating it to stakeholders in the system.
Public health officials need to establish methods to follow to integrate data and
results obtained from surveillance systems to the other stakeholders in the system.
Bauman et al. (2006) provided further evidence for diffusion and adaption efforts to be
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focused at the local level. Green, Ottoson, Garcia, and Hiatt (2009) clearly stated that the
research is not reaching public health decision makers and healthcare professionals.
Greenhalgh et al. (2008) explored the launch of a shared electronic patient record (SCR)
in England and the implementation and diffusion of the SCR within the entire healthcare
system. They emphasized using the diffusion of innovation theory because the SCR and
other technologies are not simple innovations their very nature is complex and the
implementation of such technological clusters involves developing communication
networks and time management strategies among users within the entire social system.
The Institute of Medicine (IOM, 2010) recommended updates and changes for
overhauling the National Center for Health Statistics (NCHS). The IOM stated that
improving data collection and measurement, establishing a set of health indicators, and
transforming the healthcare system would have a tremendous effect on the health of local
populations. A superior method of collaboration is needed between innovation, public
health, and medical care (Rust, Satcher, Fryer, Levine, & Blumenthal, 2010). The
Affordable Care Act of 2010 (IOM, 2010) was established to alter the existing heath care
system but innovations in public health, social, and environmental factors will need to be
improved as well. Reijn, Swann, Kretzschmar, and Steenbergen (2011) found that each
infectious disease has its own particular characteristics that must be examined. This data
must then be compared for every stage in the surveillance process in order to uncover
errors and interruptions within the system so that corrections can be made.
Adoption of the innovation. The interconnectedness of the innovation, the initial
adopters, and the rate at which the innovation is adopted are essential to adoption.
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Greenhalgh et al. (2004) stated that the standard of diffusion is to be used as a memory
aid for implementing complex innovations in diverse situations among numerous
interactions. The empirical findings associated loosely with their model include the
innovation, adoption by individuals, assimilation by the system, and diffusion and
dissemination. Greenhalgh et al. (2004) stated that these factors themselves are not
enough for the innovation to be adopted. Rogers (2003) compares adoption as a process
versus adopter categories. People are not submissive when it comes to the adoption of
innovations they engage and interact on all levels through conversations, feelings, and
evaluations.
The adopter is a principle player and team member in the adoption and innovation
process interacting with other adopters and other teams. The four aspects of adopters
from Greenhalgh et al. (2004) and Rogers (1995) include: personal perceptions,
perceptions related to the technology, what the innovation means to them, and their
adoption decision process. According to Greenhalgh et al. (2004) prior research done on
the diffusion of innovations has mainly been based on specific, modest, and commoditybased innovations where diffusion occurred from the impressions made by innovators in
the field. One must not be misled by this literature and over simplify the diffusion process
for complex technological based innovations. The successful innovator will understand
that the distribution of adoption in the target market needs to be determined by
observation and experiment (Rogers, 2003, p. 560). At this level, adoption is referred to
as team assimilation to develop structures within organizations to incorporate the
innovation.
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Rejection of the innovation. Complex innovations in service organizations are
process-based innovations and assimilations by teams, departments, and organizations
that require changes in the essence of the working environment. Greenhalgh et al. (2004)
compared the characteristics of developing simple innovations to complex innovations
and described the processes involved in each method. Most of the research on
innovations has focused on individual or simple innovations, which are developed
through simple imitation (Rogers, 1995). In order to accomplish such a multifaceted
mission, a formal decision making process must be formulated, evaluation phases must
be established, and implementation must be planned, and effort sustained throughout the
process.
All elements and procedures of initiating the innovation must be incorporated into
the planning stage. Gladwin, Dixon, and Wilson (2002) stated that it is essential to
include all information in the plan for an innovation whether simple or complex.
Omitting steps or procedures because they are common sense can be a serious error and
lead to rejection of the innovation. Gladwin et al. stated that implications for technology
innovations, such as a upgrading a surveillance system from paper to electronic, are
basically changes in the organizational structure and should be reviewed and
implemented in this fashion. All components and elements that need to be changed or
motivated must be included to ensure compliance and integration of the innovation.
Implementing the innovation. The organization’s willingness to accept the
innovation comprises their apprehension for transformation, the ability of the innovation
to incorporate into the existing scheme, and evaluation of the consequences of the
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innovation. Greenhalgh et al. (2004) stated that innovation includes system antecedents
and the systems willingness for the innovation. System antecedents are composed of the
structural components, absorptive capacity for new information, and the organizations
receptive ability for transformation. Greenhalgh et al. (2004) stated that operational and
socializing components of the organization affect the probability that the innovation will
be integrated into the organization. Provisions and promotions, devoted periods and
supplies, and the competence to appraise the innovation are the key components of
evaluating the consequences of the innovation.
The literature supports analyzing the system precursors as an aggregate because
they are multifarious, collaborative, and changeable. According to Greenhalgh et al.
(2004) a significant aspect of system integration identified by the literature is that a
system’s preliminary structural dimensions, absorptive capacity, and receptiveness should
be examined as a whole and not dissected into parts. With that in mind the individual
precursors for the structural components, absorptive capacity, and receptiveness will be
discussed. Organizational structural prerequisites that are sizeable, segregated, developed,
and focused increase compliance with integration.
Dopson, Fitzgerald, Ferlie, Gabbay, & Locock (2002) stated a significant aspect
from the healthcare literature that was mentioned extensively was the value of the
function of investigative evidence in the application of technologies (p.607). Greenhalgh,
et al. (2004) identified allocation of “slack resources” (p. 604) as an essential component
of the structural precursors, which make up only 15% of the difference between
organizations in the literature. Absorptive capacity precursors include the organization’s
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proficiencies and talent base, established associated technologies, a knowledgeable and
understanding culture, and upbeat governance dedicated to establishing communication
networks. This evidence must be digested by the existing healthcare culture, established
within their communication and social networks, and incorporated into their daily
working environment.
An organization may be prepared for innovation overall but still unequipped for a
specific innovation especially a technologically based innovation. As the organization
prepares for the innovation they acquire a state of system eloquence from which they
accept or reject the innovation (Rogers, 1995). A prospective innovation that is
successfully embraced into the organization will have the following attributes:
apprehension for transformation, the ability of the innovation to incorporate into the
existing scheme, and evaluation of the consequences of the innovation. The organization
must be prepared at all respective levels in order for the innovation to be successfully
incorporated and maintained.
Process. The organization must respect the difference between the research and
the application of the finding in the real world. The diffusion of innovation process
includes “innovation development and testing, innovation dissemination, its adoption by
a population, implementation into that population, and maintenance or sustainability of
the innovation” (Bauman et al., 2006, p. 58). The article by Bauman et al. (2006)
described the fundamentals for the propagation of any public health issue. Bauman et al.
(2006) illustrated the need for identification of key policymakers, as an essential step
throughout the process by meeting their information needs first to cement cooperation
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throughout the process. This begins the process of developing engaging partnerships that
will help implement the innovation across disciplines and boundaries. The dissemination
process is optimized when role models and leaders can be established and encouraged to
see the project through to smooth operation.
How Research Questions Relate to the Theory
This process works much better when those who will utilize the system have apart
in the initial plan to implement. In order to establish a more organized assessment and
evaluation to guide public health practitioners in their transition from paper based
surveillance systems to more elaborate electronic infectious disease surveillance systems
improvements must occur at the micro, meso, and macro level. Electronic disease
surveillance systems are complex innovations that must be accepted, adopted, and
integrated into the daily workload of all participants in the organization. Greenhalgh, et
al. (2008) stated that at the micro level these complex innovations include the basic
structure of the technology and current surveillance system, the outlook and
apprehensions of the people involved, and the current social environment. The
organizations past experiences with innovation, their willingness to participate in the
innovation, and the current working components of the innovation compose the meso
level. The CDC, NIH, and APHA and other governing bodies make up the macro level of
the organizational structure, which includes the utilitarian and sociopolitical forces
affecting the innovation.
To address innovation in the surveillance system at the micro level several
essential components of WVEDSS-NBS structure will be examined and evaluated.
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According to the literature this data should be used to establish baselines to assess
WVEDSS-NBS’s timeliness and completeness. Therefore, the current WVEDSS-NBS
will be evaluated on its timeliness and completeness by comparing it to the previous
WVEDSS. The first step is to calculate, review, and compare the infectious disease
surveillance systems timeliness or the mean reporting time of infectious diseases under
Category II of the West Virginia reportable infectious diseases of the previous WVEDSS
to the current WVEDSS-NBS.
Public health surveillance goes beyond the mere gathering, analysis, and
explanation of data for public health practices it must report this information to the
correct individuals in a time frame that allows them to take action if needed. Fedorowicz
and Gogan (2010) stated that conventional surveillance systems were designed to validate
a particular disease involved in an outbreak, stress precision and completeness while
ignoring the value of timeliness. Jajosky and Groseclose (2004) stated that timeliness is a
quantitative indicator of the surveillance systems reliability and validity and is used to
determine any time delays between operational phases. The calculation of timeliness for
this study includes how the data is to be used, the communicability of disease, and the
nature of the condition under surveillance. The second focus is on infectious disease
reporting completeness of intake forms from the previous WVEDSS and the current
WVEDSS-NBS. Doyle et al. stated in their study on notifiable infectious disease cases
reported electronically to the local health department that using the electronic system
resulted in a “2.3 fold increase in case reports” (2002, p. 866).
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Summary of Diffusion of Innovation Theory
From the first thoughts of Rogers in 1995, the diffusion of innovation theory has
developed into addressing innovation in surveillance systems in 2014. A sociotechnological innovation within infectious disease surveillance systems requires a change
of the social system or culture where the technology will be applied. The diffusion of
innovation theory represents a foundational and measurable framework to guide the
researcher on implementing innovative electronic surveillance systems around the world.
Public health officials can use the research on the theory to integrate and understand the
vast amount of electronic data obtained from electronic surveillance systems. Adopters of
an innovation go through a process of adoption in which they either accept or reject the
innovation. Adoption and subsequent implementation of the innovation require extensive
planning, stakeholder involvement, and dissemination of the innovation across the
organization.
Literature Related to Timeliness and Completeness
This study focused on improving the assessment of infectious disease data
retrieved from surveillance systems. In order to improve surveillance system evaluations
this study identified areas within the WVEDSS-NBS where more complete epidemiology
and surveillance system data may be missing or where improvements can be made to the
system. The WVEDSS-NBS, which is being integrated with EHR, will be compared to
the old WVEDSS and evaluated on system attributes of timeliness and completeness.
Since the WVEDSS-NBS is now linked to NEDSS, the national system, and therefore the
WHO, the international system, they are obligated to follow the IHR (2005). The WHO
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(2008) stated that the IHR (2005) is a binding international law that went into effect on
June 15, 2007 and it governs the criteria for reporting epidemiological data to the WHO,
the WHO’s response, and requires the strengthening of member countries surveillance
systems and response to public health risks.
Evaluation of Epidemiology Surveillance and Response
Several countries have performed evaluations of epidemiology surveillance
efforts. The components discussed will focus on methods for epidemiology surveillance
and response, public health laboratory services, and the public health educational
infrastructure. Nsubuga et al. (2010) evaluated four countries in Africa to recognize
accomplishments and miscalculations using the Integrated Disease Surveillance and
Response (IDSR) strategy. The Africa Regional Office (AFRO) and the WHO developed
the IDSR in 1998. This knowledge was used to build a guide to address the IDSR key
components for evaluating integrated surveillance systems. Taboy, Chapman, Albetkova,
Kennedy, and Rayfield (2010) investigated the integration of surveillance using the IHR
(2005) to create a set of tools to address the challenges of the action theme to create a
sustainable world health network for international collaboration. Takian, Petrakaki,
Cornford, Sheikh, Barber, and NHS CRS Team (2012) assessed England’s
implementation of a national EHR because all WHO member States and partners are
undertaking these challenges. Case-by-case evaluations were used for comparison of
system attributes between surveillance systems and to verify compliance with IHR
recommendations.
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The evaluation and comparison of case studies allowed the researcher to pinpoint
unique aspects of the surveillance system to begin a discerning discussion about
collective themes and unique encounters. According to Takian et al., and National Health
Service Care Records Service (NHS CRS) Team (2012) integrated case study evaluations
can address multiple levels of the surveillance system and identify the social, technical,
and cultural environments. Takian et al. used a case-study design and interpretive
approach to evaluate the implementation of England’s NHS CRS over a 30-month period
from September 2008 to March 2011. The investigation of case studies is critical in
establishing the sensitivity of the surveillance system (Watkins, Martin, Kelly, Madin, &
Watson (2009). Amirfar, Taverna, Anane, and Singer (2011) described the creation of
quantitative quality of life measures to be integrated with a new EHR, the clinical
decision support system, for New York Cities’ outpatient population. Amirfar et al.
analyzed the creation of the CDSS as they went through the planning, developing, and
implementing stages to improve population health.
Amirfar et al. (2011) took advantage of existing innovations in technology and
EHR to improve the quality of patient care in New York City using established
quantitative data: 10 TCNY measures. Many researchers (Wamala et al., 2010; Nsusbuga
et al., 2010; Takian et al., 2012; & Taboy et al., 2010) have approached the problem
(incomplete evaluation of surveillance systems and data quality) by evaluating their
systems using the IHR (2005) and IDSR tools developed by the World Health
Organization. Wamala et al. (2010) stated that their evaluation of Uganda for compliance
with the IHR (2005) included five core capacities: infectious, chemical, zoonosis, food-
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safety, and radio-nuclear. Using the technical guidelines outlined by the IDSR they
identified strengths and weaknesses in WHO’s approach to improving the evaluation,
implementation, and collection of data within surveillance systems. The major strength of
their study was it identified gaps in applying the IHR (2005) and uncovered worldwide
security issues. Africa needs to address these issues at the national level and the WHO at
the international level because no established legal framework is in place to support and
enable the required procedures to comply with the IHR (2005). Applying the strategies
outlined in the IDSR allowed them to reexamine their existing goals, objectives, and
interventions in an organized and structured way.
Reviewing these constructs provided them with ammunition to develop new
objectives in line with WHO's IHR (2005). Nsubuga et al. (2010) also focused on the
implementation of the IDSR in Africa but broadened their research to include four
countries. One major weakness of the IDSR, their tool for evaluation, is that it is still
evolving and the data they obtained was mostly qualitative. Taboy et al. (2010) used the
Integrated Disease Investigations and Surveillance (IDIS) tools developed by the
Laboratory Systems Branch of the CDC and the U.S. Defense Threat Reduction
Agency’s Cooperative Biological Engagement Program (CBEP) to focus on a systems
approach for outlining effective implementation approaches.
The IDIS tools enabled evaluators to combine their ideas, thoughts, and critiques
of the system to identify proficiencies and encourage dialogue on sustainable local, state,
national, and international communication networks. Lack of sufficient technology and
methods to interlink the CDC and CBEP may have had detrimental effects in other areas
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of the public health system. Takian et al., and NHS CRS Team (2012) stated that their
longitudinal approach to the social and technological assessment of England’s NHS CRS
occurred simultaneously with the implementation process. The ability to change focus
from end point evaluation of surveillance data to analyzing changes as they take place
within the system is one of their major strengths. Thus, it was also a weakness because it
could show only a limited part of implementation, the predicted research plans were
inaccurate, and the length of the study was short.
Attributes of Surveillance Systems
To accomplish a thorough review of the surveillance system the diffusion of
innovation theory was utilized to connect the system attributes examined. According to
Watkins et al. (2009) system attributes for measuring the sensitivity of a surveillance
system should include timeliness, completeness, and the geographic and demographic
data of the population. Williams, Vally, Fielding, and Cowie (2011) followed the
recommendations of the CDC to establish disease registries to improve the completeness
of intake forms fields and allow the user to incorporate additional public health
information. The authors also identified under reporting of communicable disease as a
cause for concern regarding the completeness of data. The IDIS tools developed by the
CDC and CBEP developed pathogen specific templates that were used to compare
completeness of intake forms from the old system to the new system (Taboy et al., 2010).
Nsubuga et al. (2010) stated that the integration of existing surveillance systems with the
electronic health record (EHR) increased the efficiency of the system. In order to ensure
timeliness and completeness across the whole health system an all-inclusive approach is
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required because of the complex nature and multiple interrelated factors surrounding
technological innovations.
Timeliness
In this study, the timeliness or the reporting time of infectious diseases under
Category II of the West Virginia reportable infectious diseases of the previous WVEDSS
was compared to the current WVEDSS-NBS. Timeliness was evaluated by compliance
with Category II guidelines that notifiable infectious diseases are reported within the
recommended time period, average time lags, and the cumulative time lag between each
step in the surveillance process (Yoo et al., 2009). The WHO (2008) outlined guidelines
on timeliness that are assessed by measuring the time taken for each step from disease
onset to International reporting. Jajosky and Groseclose (2004) stated that timeliness is a
quantitative indicator of the surveillance systems reliability and validity and is used to
determine any time delays between operational phases. Timeliness is a key element and
should be used as a consistent evaluation and measurement tool of surveillance systems
(Yoo et al., 2009). Perhaps the major error that has been made in the past in the
measuring of timeliness is that it has been assessed as a single process.
Definition. In the literature timeliness has been measured as the speed between
steps in the surveillance process, the time between disease onset and reporting to local,
state, national, and international agencies, and as the time between proxy values
established for disease onset and disease reporting. According to Reijn et al. (2011) no
standard quantitative measure for timeliness in surveillance systems has been established.
I will evaluate timeliness on two factors: mean reporting time and within 24 hours of
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disease onset, the standard for Category II infectious diseases. Yoo et al. (2009) stated
that timely reporting is effected most by the interval from disease inception to diagnosis.
Yoo et al. (2009) stated that previous research has indicated that the surveillance steps of
infectious disease reporting vary from system to system and from one infectious disease
to another. Category II infectious diseases of WV will be considered reliable if they are
reported within 24 hours to the LHD.
The most important aspect in evaluating the timeliness of a surveillance system is
to establish a standard definition and establish a quantifiable factor to measure it.
Timeliness was defined in terms of mean reporting time and the 24-hour standard.
Jajosky and Groseclose (2004) collected data on the National Notifiable Disease
Surveillance System (NNDSS) and suggested using the earliest known date of disease
onset as the starting point for the measurement of timeliness, varying by disease. The
comparison of timeliness across surveillance systems and from paper to a Web-based
server illustrated key factors causing delays in the timely reporting of infectious diseases.
Results of Previous Studies. Reijn et al. (2011) stated that study methods for
timeliness varied from comparing paper to electronic systems and timeliness measures
across boundaries. In their evaluation of the Dutch Municipal Health Services (MHS) on
timeliness they identified two key intervals for timeliness as the time period between the
onset of symptoms and MHS notification, and between laboratory diagnosis and MHS
notification. They used distribution of means as their statistical test to evaluate timeliness.
Vogt, Spittle, Cronquist, and Patnaik (2006) illustrated how a LHD could evaluate the
Colorado Electronic Disease Reporting System (CEDRS) for timeliness and
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completeness. Timeliness was defined as the time period between “specimen collection
date” and “report date” for each patient and they compared them through distribution of
mean. Records were said to be complete if all required fields were filled. Most fields
were found to be complete except for the “diagnosis date” field but a new field was
created “test result date” to substitute for the date of diagnosis. Their results prompted
training of disease investigators to fill out intake forms completely with the hope that
future evaluations will yield improved timeliness and more complete data. I measured
timeliness from the date of diagnosis to the reporting date to the state health department
and evaluated each disease on the distribution from the mean.
In order to reduce the spread of infectious diseases continual efforts need to be
applied to improve the timeliness of surveillance systems. Reijn et al. (2011) stated that
infectious disease surveillance systems (IDSS) should be regularly evaluated for each
step in the system for each disease within the system. Reijn et al. found that the
proportion of infectious diseases reported to the LHD varied by disease, 0.4% for
shigellosis and 90.3% for HAV infection. They compared the median incubation period
of each infectious disease to the median time it took to report the disease to the health
department. They used incubation period as their standard measure and reliability marker.
Some of the most common reasons for delayed reporting are patient’s recognition of
symptoms, communication issues, missing data, incorrect data, disease specific
incubation periods, and laboratory-related delays. Reijn et al. (2011) illustrated that
electronic laboratory reporting (ELR) has improved the timeliness in some nations and
concluded that an international standardization method for measuring timeliness be
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supported. The WVEDSS-NBS has not implemented ELR within its system however a
delay in diagnosis was found to be a common disruption of timeliness in the next study
even though they used data from an ELR system.
The evaluation of data from surveillance systems being assessed for timeliness
varies because each study examines different diseases and measures of timeliness. Yoo et
al. (2009) evaluated over 40,000 infectious disease records from an electronic system that
collected data in 2000. They found that the greatest time delay stemmed from the delay in
diagnosis from the clinical side and from the excess time spent on lengthy laboratory
tests. They found that the total time from disease onset to reporting to the local health
department ranged from six to twenty days and varied from one disease to another.
Nicolay et al. (2010) evaluated the timeliness of different species of Salmonella and
found that timeliness varied even among the different species. They found that
notification from physicians was faster than laboratory reporting the opposite effect of
what was uncovered by Yoo et al. (2009).
However, most studies found that electronic reporting resulted in an improvement
in all system attributes especially timeliness. Effler, Ching-Lee, Bogard, Ieong,
Nekomoto, and Jernigan (1999) compared an electronic reporting system to the previous
conventional system and found a 2.3 fold increase in infectious disease reporting with the
new system. The CDC (2005) stated that in New Jersey, which has a Web-based server
like WVEDSS-NBS implemented in 2001, the number of cases reported from 2002 to
2004 doubled and that the average days for case reporting dropped from 28 days in 2002
to 3-4 days in 2004. In Massachusetts the implementation of several interventions,
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including Web-based infectious disease surveillance system, improved timeliness by
decreasing median reporting times from 454 days in 2004 to 26 days in 2008. Lazarus, et
al. (2009) stated that despite all of the improvements made in surveillance systems
across the country some important internal mechanisms still depend on people. Even
though we have come a long way and improved several qualitative and quantitative
aspects of infectious disease reporting training and integrating primary stakeholders
within the system remains essential.
Past Problems. Electronic reporting, electronic health records, and electronic
laboratory reporting have the potential to improve all system attributes. Wurtz and
Cameron (2005) illustrated that despite these obvious improvements in infectious disease
surveillance the physician must still do their part in submitting a comprehensive and
well-timed case report. Lazarus et al. (2009) quantified that electronic laboratory
reporting is held in high regard by experts in the field but without integration with the
electronic health record the ELR is deficient in essential information for case detection
and the condition of the disease. Even though most states have adapted to national
guidelines by using the NEDSS equivalent software to upgrade their paper based systems
to electronic or Web-based servers many problems still exist in establishing standards for
information exchange. Nicolay et al. (2010) stated that research has proven that
implementation of electronic reporting will decrease timeliness and increase the
completeness of surveillance statistics.
The CDC (2005) stated that establishing secure channels and standards for the
exchange of infectious disease, ELR, and EHR data between public health officials and
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clinicians remains a challenge. Heisey-Grove, Church, Haney, and Demaria (2011)
suggested that direct integration of data from the EHR would decrease the timeliness of
reporting infectious disease outbreaks. As the interface between clinicians and public
health officials improve the data becomes more streamlined and universal. In the past
health data was faxed, mailed, or emailed to the local or regional epidemiologist to be
entered into the state system. The epidemiologist entered this data into the system
sometimes weeks after the information had been received or the notifiable condition had
transpired. The CDC (2005) reported that many (10-85%) of these cases never made it to
the national level and previously states used over 100 different systems to send reports to
the CDC. A review of the literature has revealed that many definitions and standards of
measurement for timeliness have been used in the past. Madoff, Fisman, and Kass-Hout
(2011) concluded that incorporating the Internet into surveillance reporting would
improve timeliness, sensitivity, and completeness of surveillance system data. I followed
the CDC’s recommendations for assessing timeliness in order to establish a baseline for
timeliness comparison by disease category for future research. According to the CDC
(MMWR, 2001) improved timeliness allows for adequate and accurate development of
policies and interventions. Computerized technology allows for the assessment of
timeliness to be completed routinely on each step in the public health surveillance
system.
Timeliness of Electronic Data Systems. Electronic disease reporting has
become the standard by which all other reporting is to be compared. According to several
researchers (Reijn et al., 2011; Yoo et al., 2009; Nicolay et al., 2010; Doyle et al., 2002)

61
electronic disease reporting has improved the timeliness of infectious disease outbreak
notification. In addition these authors and the CDC (2005) recommend that states
integrate ELR into their existing systems to improve timeliness because laboratory tests
are used to confirm most infectious diseases, labs are important members of the system,
and laboratories can be used for other aspects of public health surveillance. Evaluating
infectious diseases by integrating the above systems improves timeliness and supports
more complete evaluations since infectious diseases must be assessed individually
because of critical diagnostic criteria. Nicolay et al. (2010) stated that research has
proven that implementation of electronic reporting will decrease timeliness and increase
the completeness of surveillance statistics. Electronic data and evaluation methods at the
local, state, national, and international level allows for more complete assessment of
infectious diseases and their spread around the globe.
Completeness
Completeness was measured by the ratio of incomplete fields to complete fields
of required data items on the WVEDSS-NBS intake form that has been filled. Lazarus et
al. (2009) stated that completeness could be measured as the percentage of the essential
statistics required identifying a particular infectious disease. According to Doyle et al.
(2002) infectious disease reporting completeness identifies those notifiable cases that
have been reported to the local health department. The completeness of intake forms is
crucial to the proper accounting of cases of infectious disease within a population.
Without this vital information to guide epidemiologist and other public health officials in
the diagnosis of notifiable infectious diseases, outbreaks may be missed and epidemics
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may occur. I evaluated completeness in this study by the ratio of incomplete fields to
complete fields.
Definition. Lazarus et al. (2009) stated that the main issue with using data fields
on intake forms to measure completeness is the agreement of what is required for each
form. I assumed in this study that all fields are required for a particular case or that each
data field within a section is entered correctly. I also assumed that a data field is complete
if there is an entry for that field.
Results of other studies. Lazarus et al. (2009) found in their study on
completeness that failing to report an individual case with a notifiable condition, false
positive, was worse than reporting case that later turned out to be negative, false positive.
The false positive case wasted valuable time but the false negative case actually
decreased the efficacy of public health interventions. Comprehensive, itemized case
information is needed for public health prevention programs that are usually not available
from conventional manual forms. In a study performed by Effler et al. (1999) they found
using capture/recapture methods that out of 21 data fields common to both electronic and
paper intake forms, electronic forms were considerably more complete; thus identifying
that the electronic format to be far superior to the conventional paper or manual format.
This leads to the evaluation of the intake forms submitted electronically and the
intake forms submitted by the conventional method. Heisey-Grove et al. (2011) stated
that they began using the optical character recognition (OCR) form in 2004 for Hepatitis
C and from 2005 to 2008 the amount of intake forms received increased dramatically and
the percentage complete intake forms increased by three percent. They used the case
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ascertainment method to analyze completeness of intake forms. Doyle et al. (2002)
reviewed published articles in the U.S. from 1970 to 1999 that evaluated disease
completeness quantitatively by comparing the number of forms received by comparing
this number to the number received by another collection method. The degree of
completeness in these studies ranged from 9% to 99% and was intensely related to the
disease studied. According to Sickbert-Bennett et al. (2011) disease completeness varied
not only by disease in their retrospective cohort study but also by healthcare system.
Their results showed that disease specific completeness varied from 0% to 82% and
completeness overall was quite low for all diseases. These results are important because
they identify several factors essential to the evaluation of infectious disease completeness
data.
It is important to evaluate infectious disease completeness by each disease under a
specific Category and to examine each reporting source independently to uncover
reporting patterns. Jajosky and Groseclose (2004) stated that mandatory infectious
disease reporting in the United States varies from 9–99% and that active surveillance
completeness was much better than passive disease surveillance systems completeness.
They also indicated that the timeliness of active and passive were relatively the same.
This information is important because it links the system attributes of timeliness and
completeness and emphasizes the significance of evaluating them simultaneously before
drawing any conclusions about the nature of the system. I evaluated disease completeness
by assessing the ratio of incomplete to complete fields on both datasets intake forms.
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Past Problems. Evaluating a system based on one attribute will highlight key
aspects of the system related to that attribute only and will not address other key
attributes of the system. The NEDSS has outlined standards for the evaluation of
surveillance systems to improve the accuracy, completeness, and timeliness of infectious
disease reporting in the United States. The CDC along with health departments across the
nation is working to improve the public health infrastructure by integrating infectious
disease surveillance systems with clinical information systems. In essence they are
rebuilding the medical and public health infrastructure as one united system. HeiseyGrove et al. (2011) stated that for this to take place more education is needed to inform
the clinical professionals about the importance of submitting this data and why it is
important to collect it. Training on electronic medical records and other electronic health
information systems does not occur in medical school and needs to be on the job training.
Manually submitted data from clinicians has been a source of partial, inaccurate,
and untimely information movement in the past. Clinicians outreach programs are
essential according to Lazarus et al. (2009) because despite considerable progress in
electronic reporting many significant surveillance procedures still rely on practitioner’s
manual entry and submission of data. The evidence has demonstrated that the timeliness,
completeness, and efficiency of data have been greatly affected by data originating from
clinicians. Comprehensive, specific infectious disease case information, which goes
beyond the standard intake form, is needed for public health integration, policies, and
intervention planning and implementation.
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In the past public health infectious surveillance system data was sent to the CDC
using multiple methods (fax, email, and paper) compiled by hundreds of different
surveillance programs (WV DHHR, 2014). According to Jajosky and Groseclose (2004)
the United States public health system and the CDC have created a plan to improve the
public health infrastructure and implementation in America. The NEDSS was developed
to help states across the country to integrate their surveillance systems (like WVEDSS in
WV) with the national system (WVEDSS-NBS) and the electronic health record. The
NEDSS promises to improve the timeliness and completeness of infectious disease
surveillance information exchange.
Previously measuring the completeness of disease reporting was a difficult task
but necessary to correctly elucidate infectious disease incidence or to make infectious
disease comparisons across national and international boundaries. Doyle et al. (2002)
explained reasons from the literature for incomplete infectious disease reporting in the
past. The reasons included safety and privacy issues, misinterpretation of the law
regarding notifiable conditions, ignorance of required infectious disease to report,
clueless about where and to whom to report, and inadequate punishment for not
reporting. According to Sickbert-Bennett et al. (2011), the evaluation of the NEDSS in
the United States is inadequate and previous studies differ on their assessment of
reporting completeness. This variability in the measurement of reporting completeness
makes the relationship and combination of assessment data difficult to evaluate.
Completeness of electronic data systems. Automated reporting may be the
future of electronic disease surveillance systems. Effler et al. (1999) stated that laboratory

66
staffs are active participants in infectious disease reporting; electronic laboratory
reporting (ELR) could improve the timeliness and completeness of infectious disease
reporting. In the conventional system clinicians and other health professionals are passive
participants in infectious disease reporting. The estimated completeness of the
conventional system evaluated by Effler et al. (1999) was 38% (95% CI [37%-39%])
compared to the electronic system, which was 80% (95% CI [77%-82%]). Heisey-Grove
et al. (2011) agreed that the conventional system was always incomplete especially in the
area of vital risk prevention data fields. Doyle et al. (2002) stated that active surveillance
has proven to have a more complete case record than passive surveillance. The ELR is a
useful and timely tool in infectious disease surveillance.
Although electronic laboratory reporting (ELR) may be timely it still lacks vital
clinical information essential in determining and localizing infectious disease outbreaks.
Lazarus et al. (2009) stated that ELR may be the gold standard for disease reporting but
the clinical data found in the EHR is crucial for reporting completeness. Doyle et al.
(2002) illustrated that the complete integration of all systems as one automated systems is
the future of surveillance systems, ELR, and the EHR. Much like the NEDSS and the
CDC are doing in the U.S. restructuring the clinical system and public health systems into
one complete health system.
Summary
According to Taboy et al. (2010) the International Health Regulations (IHR,
2005) were created as a set of tools to address the challenges of the action theme to create
a sustainable world health network for international collaboration. Additionally they were
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established to identify standard definitions or procedures for system attributes: timeliness
and completeness. Several studies have suggested that the quality of surveillance system
data is unknown because the assessment protocol for surveillance has yet to be
established. The IHR (2005) took effect in 2007 and complete implementation was
supposed to occur by the end of 2012 in WHO member states. This study filled the gaps
in the literature by providing the most common definition and measures for timeliness
and providing the meaning and a standard measure of completeness. A quantitative study
design was implemented to examine the existing measures used in WVEDSS-NBS with
the old system WVEDSS to establish baseline data, definitions for system attributes and
the overall effect of the integration with the EHR.
The research method that is discussed in more depth in Chapter 3 will be a quasiexperimental interrupted time-series design comparing two data sets before and after a
technological intervention. The evaluation of data is an integral part of surveillance
systems access and usage.
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Chapter 3: Research Method
In spite of the improvements to surveillance systems the assessment of the
reporting of infectious disease data is imperfect and incomplete. The purpose of this
study was to identify areas where more complete epidemiology and surveillance system
data is missing or where improvements can be made to the system. The system attributes
(timeliness and completeness) of WVEDSS-NBS were compared with the previous
system, WVEDSS. All research is based on some basic principle or worldview; the postpositivist view was used in this study.
This chapter discusses the research design and rationale, connection of research
design and variables to the research questions, time and resource constraints, research
questions, methodology, threats to validity, and a summary. This study used the quasiexperimental, interrupted time-series design, which was analyzed using quantitative
methods. To address the goals of this study, the diffusion of innovation theory was used
to incorporate the multifaceted components of technological innovation with archival
infectious disease surveillance data.
Research Design and Rationale
Research Variables
The key variables in this study were the cases/reports, timeliness, and
completeness. The key independent variables were the system attributes of timeliness and
completeness. The key dependent variables were the cases/reports of Category II
infectious diseases. In order to accomplish these goals, the current WVEDSS-NBS was
evaluated on its timeliness and completeness by comparing it to the previous WVEDSS.
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Research Design and Connection to the Research Questions
This study used the quasi-experimental, interrupted time-series design along with
the diffusion of innovation theory in order to evaluate WVEDSS and to compare it to
WVEDSS-NBS on a case-by-case basis. The case study comparison was used to identify
factors that may contribute to disruptions within the surveillance system. According to
Harris, McGregor, Perencevich, Furuno, Zhu, Peterson, and Finkelstein (2006) and Harris
et al. (2004), nonrandomized, quasi-experimental designs are frequently used when
randomized control trials are not appropirate or practical. In medical informatic studies,
the quasi-experimental design is intended to evaluate nonrandomized interventions before
and after their implementation; which the before and after interventions are then
compared to nonrandomized control groups. Harris et al. (2006) and Ho, Peterson, and
Masoudi (2008) explained that interuppted time-series designs are the strongest among
the quasi-experimantal designs for establishing causality. In interuppted time-series
designs, a series of observations are evaluated before an intervention (the interruption)
then a series of observations are evaluated after the intervention.
Time and Resource Constraints
The only time and resource constraints were in acquiring the data sets from the
state epidemiologist for Category II infectious disease from the WVEDSS, the archived
data, and the WVEDSS-NBS, live data. The regional epidemiologist and the state of
West Virginia provided data from the current and previous version of the WVEDSS
database. Other sources of information on infectious disease surveillance came from the
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following websites: WHO, CDC, Ohio County Public Health Department, and West
Virginia State Department of Health and Human Resources.
Research Questions
This study examined the following three research questions.
4. Is there a difference in mean reporting time of Category II reportable
infectious diseases between the two data systems (WVEDSS & WVEDSSNBS) in West Virginia?
H01 - There is no difference in mean reporting time of Category II infectious
diseases between WVEDSS and WVEDSS-NBS.
Hₐ1 - There is a difference in mean reporting time of Category II infectious
diseases between WVEDSS and WVEDSS-NBS.
5. Is there a difference from the 24-hour standard (time delay) of the infectious
diseases under Category II of the West Virginia reportable infectious diseases
for both data sources?
H02 - There is no difference from the 24-hour standard for one or both data
sources.
Hₐ2 - There is a difference from the 24-hour standard for one or both data
sources.
6. Are the required fields (Identifier, DOB, Current Sex, State, County,
Reporting Facility Identifier, Program Area, Jurisdiction, Date Received by
Public Health, Specimen Source, Date Specimen Collected, Resulted Test,
Organism, Add Test Result Button) complete for both data sources?
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H03 - There is no difference in completeness of the required fields for one or
both data sets.
Hₐ3 - There is a difference in completeness of the required fields for one or
both data sets.
Methodology
The scope of this paper included the evaluation and comparison of the WVEDSS
and WVEDSS-NBS to improve reporting times, prevention, and interventions for
Category II infectious diseases in West Virginia. Category II reportable infectious
diseases were chosen because they must be reported to the LHD within 24 hours and it
includes any unusual or emerging infectious disease. The diffusion of innovation theory
was used to understand the scope, objectives, and system attributes (identified as
timeliness and completeness). This data was used to assess the effectiveness of the local
health department’s policies and prevention strategies, intervention, and control measures
for disease outbreaks to create more complete surveillance system data.
Population
The target population was the regions of West Virginia. This census data has been
compiled over a period of four years from 2007-2010. The total population in West
Virginia under surveillance in 2010 according to the U.S. Census was 1,852,994 and
estimated to be 1,855,413 for 2012.
Sampling and Sampling Procedures
Sampling was non-random by convenience of data submitted for WVEDSS and
WVEDSS-NBS for Category II infectious diseases in WV. I obtained permission for all

72
state data for Category II infectious diseases. Category II infectious diseases were chosen
for this study because they include emerging infectious diseases and any other unusual
conditions. According to Sahal, Reintjes, and Aro (2009), it is beneficial to study many
different diseases within a surveillance system to get a larger representation of how the
entire population is affected. All data reported for the above infectious diseases from
WVEDSS (2007-2010) and WVEDSS-NBS (March, 2012- March, 2014) for Category II
infectious diseases (Table 2) was included in the sample.
Power analysis to ensure appropriate sample size. Power analysis was
conducted to ensure that the sample size from available secondary data would meet a
minimum level of 95%. They following parameters were included in G*Power 3.1.7
(Faul, Erdfelder, Lang, & Buchner, 2007 and Faul, Erdfelder, Buchner, & Lang, 2009):
Test family (Exact), Statistical test (Inequality, two independent groups (Fisher’s exact
test), Type of power analysis (A priori: Compute required sample size), two tails,
proportions dataset 1 (WVEDSS) = x1, proportion dataset 2 (WVEDSS-NBS) = x2, α =
0.05, Power (1- β err problem) = 0.95, and allocation ratio (N1/N2) = 2. The proportion
sizes (x1, x2) were determined from the West Virginia DHHR website on infectious
disease surveillance cases from 2007-2014. The following outputs were determined:
sample size haemophilus influenza invasive 1 = 12, group 2 = 24, total sample size = 36;
sample size hepatitis type A acute group 1 = 417, group 2 = 834, total sample size =
1251; sample size hepatitis type B group 1 = 495, group 2 = 990, total sample size =
1485; sample size pertussis group 1 = 7, group 2 = 14, total sample size = 21; sample size
rabies human group 1 = 11, group 2 = 11, total sample size = 22; sample size rubella

73
group 6= 100, and total sample size = 150. As there were thousands of cases available for
analysis among the WVEDSS and WVEDSS-NBS datasets, there was no issue with
obtaining minimum sample size.
Archival Data
The WV State Infectious Disease Epidemiologists were contacted to receive
permission to work with archival data within the WVEDSS (2007-2010) and WVEDSSNBS (March, 2012- March, 2014). Authorized users manually enter data into disease
reporting forms (specific for each disease) on the Web-based server WVEDSS-NBS.
Permission was obtained from the state’s IRB committee and Walden’s IRB committee
approved a data use agreement. The state epidemiologist blinded the data and a HIPPA
and consent form to use the data for research purposes was signed before data was
released to the student. The data were stored on a separate hard drive after being blinded
by state officials.
Operationalization of Constructs
The WVEDSS-NBS outlined the procedures for preparing a disease report for
notifiable infectious diseases on the West Virginia Department of Health & Human
Resources (WVDHHR) website. They provided a quick reference guide for reporting
infectious diseases into WVEDSS and other resources to guide users on submitting
complete and up to date information. The epidemiologist review all reportable cases and
investigates each case individually to confirm the infectious disease responsible. Each
disease under Category II in West Virginia has a separate intake form that was available
for entry online. Once the health professional entered the initial intake information into
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WVEDSS, the epidemiologist then is able to check the information and send that
confirmed infectious disease to the state office, which sends it to the CDC.
Data Analysis
All data was stored in Microsoft Excel and imported into SPSS for statistical
analysis. The two datasets were entered into an excel document and this data was
reviewed to address issues in reliability, credibility, validity, and practicality of
information. I assessed the dataset’s reliability and credibility by evaluating the level of
bias and confidence intervals, validity of collection method and practicality of the
datasets was assessed using triangulation when possible and verified by the source’s
dependability (The Assessment Capacities Project, 2014). According to Harris, et al.
(2006) statistical analysis of quasi-experimental design using interrupted time-series data
can detect variations in mean and in the slope or intercept as an effect of the intervention.
Descriptive statistics was performed to get an understanding of the data.
Research questions evaluated differences in mean reporting time, the 24-hour
standard, and complete fields (DOB, gender, etc.) of the two data sets using independent
samples t test. The t test was chosen because it was appropriate for comparison of means.
The assumptions of the t test are bivariate independent variables, continuous dependent
variable, each observation of the dependent variable was independent of the other
observations of the dependent variable, and the dependent variable has a normal
distribution, with the same variance, σ2, in each group (Weaver, 2004). If some variables
are not normally distributed the non-parametric test, Wilcoxon Mann-Whitney was used.
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The timeliness of Category II infectious diseases was evaluated by comparing the
mean reporting times and the difference from the 24-hour standard. Completeness was
measured by examining the number of fields completed on the intake forms for each form
submitted under Category II. A field was counted as complete if there was an entry for
that field on the intake form. I counted the number of incomplete fields per form and
compared that to the number of required complete fields (#incomplete/#complete). Table
3 outlined how each research question and variables were evaluated using statistics.
Table 3
Research Questions and Statistical Test
Research Question
Is there a difference in
mean reporting time of
Category II reportable
infectious diseases
between the two data
systems (WVEDSS &
WVEDSS-NBS) in West
Virginia?
Is there a difference from
the 24-hour standard (time
of diagnosis to reporting
to LHD) of the infectious
diseases under Category II
of the West Virginia
reportable infectious
diseases for both data
sources?

Variables
Mean reporting time =
time reported – time of
diagnosis

The data collected from
the Category II diseases
(Table 2) will be coded by
Group (1-5) and case
number (e.g. Group 1-1
(H. influenza - case 1),
Group 2-2 (hepatitis A –
case 2) and the time
associated in reporting
will be assigned to each
case. (e.g. Group 1-1 ≤ 1)
Group 3 = hepatitis B
Group 4 = pertussis
Group 5 = rabies
Group 6 = rubella
(Report Date – Diagnosis
Date ≤ 1 day)

Statistical Test
t test – comparison of
mean difference.

t test – comparison of
means.
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Are the required fields
complete for both data
sources?

The Required Fields will be
coded alphabetically:

t test – comparison of
means.

dentifier = A,
DOB = B,
Gender = C,
State = D,
County = E,
Reporting Facility Identifier =
F,
Program Area = G,
Jurisdiction = H,
Date Received by Public
Health = I,
Specimen Source = J,
Date Specimen Collected = K,
Resulted Test = L,
Organism =M,
Add Test Result Button = N
The number of incomplete
fields will be compared to
number of incomplete fields.
Ratio = #Incomplete
fields/#Complete fields

Threats to Validity
Threats to External Validity
There are four basic threats to external validity: Selection bias; constructs,
methods, and confounding; the real world versus experimental world; and history effects
maturation (Steckler & McLeroy, 2008). Selection bias was overcome because the two
groups being compared will include all cases in West Virginia. This information was
applied across the entire state by comparing the different regions within the state. To
ensure the validity of constructs such as timeliness the step from disease diagnosis to
disease reporting was measured and compared between the two groups. If the steps in

77
reporting have changed from one group to another then this was noted and an explanation
provided in the literature. Maturation was discussed as a threat to internal validity.
Threats to Internal Validity
Maturation of individuals within the surveillance system does happen over time
but new members of society are born and growing up within the system. The researcher
was careful to make generalizations regarding snap shots in time versus over time. Quasiexperimental experimental designs have several threats to internal validity including
nonrandomization, confounding variables, and regression to the mean (Harris, 2006).
Other weaknesses or limitations in the study design are controlling for maturation effects
and regression to the mean. Regression to the mean and maturation are both threats to
internal validity and possibilities in this study. Regression to the mean was a possible
threat because the intervention may or not be the reason for an improvement in
surveillance. Maturation effects were a possible threat in concluding that the intervention
caused an improvement in reporting. In interuppted time-series designs there are a series
of observations which are interrupted by the intervention (WVEDSS-NBS) then a series
of observations after the intervention. With the series of observations before and after the
intervention it is easier to address and control for maturation effects and regression to the
mean.
Ethical Procedures
I obtained permission from the Walden University IRB committee. A signed
agreement was made with the state infectious disease office to gain access to the
appropriate blinded data. All ethical concerns were addressed by receiving data that was
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void names and other identifying characteristics of participants. Data were be protected
again by its anonymous nature and only included pertinent information needed to
evaluate and compare across surveillance systems. Data were stored in a separate
portable hard drive that only I had access to and will be stored for 5 years after
dissertation is complete and then destroyed. If there is a breach of confidentiality the
Walden IRB committee and this committee members will be notified immediately.
Summary
In spite of the improvements to surveillance systems the assessment of the
reporting of infectious disease data is imperfect and incomplete. In order to fulfill the
purpose of this study a quasi-experimental design was used. The WVEDSS and
WVEDSS-NBS were evaluated on a case by case basis and then compared through
system attributes. This study recognized significant differences between WVEDSS
(2007-2010) and WVEDSS-NBS (March 2012 to March 2014) to identify factors that
contributed to disruptions within the surveillance systems. Chapter 4 will discuss data
collection, descriptive statistics of the sample, results, and a summary.
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Chapter 4: Results
Introduction
The purpose of this study was to identify key areas in the process from disease
diagnosis to disease prevention to improve the WVEDSS-NBS. The essential elements of
the Category II VPID reported within the time frame chosen were identified; they were
then examined quantitatively using the quasi-experimental, interrupted time-series design
along with the diffusion of innovation theory. The difference between mean reporting
times and the 24-hour standard between the two data sets was evaluated for timeliness.
The required fields were assessed for completeness. Secondary data were used to
evaluate the following research questions and hypotheses.

1. Is there a difference in mean reporting time of Category II reportable infectious
diseases between the two data systems (WVEDSS and WVEDSS-NBS) in West
Virginia?
2. Is there a difference from the 24-hour standard (time delay) of the infectious
diseases under Category II of the West Virginia reportable infectious diseases for
both data sources?
3. Are the required fields complete for both data sources?
Chapter 4 will discuss the time frame for data collection, discrepancies in data
collection from the Chapter 3 plan, baseline descriptive and demographic characteristics
of the sample, challenges to implementation as described in Chapter 3, statistical
assumptions, and results.
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Data Collection
Data collection did not proceed as planned in Chapter 3. The time frame for data
collection was 6 months from preliminary Walden IRB approval, October 28, 2014 to
final approval on February 28, 2015. The time frame was extended because the West
Virginia state epidemiology office made changes to the data request based on their access
to the data in question. After the Walden IRB processed these changes and requests, data
was made available.
The Chapter 3 plan included the following Category II Infectious Diseases: H.
influenza, hepatitis A, hepatitis B, pertussis, rabies, and rubella. However, while working
with the West Virginia state epidemiology office, the Category II infectious diseases they
chose were vaccine preventable infectious diseases because this was the most complete
data available. Therefore, the following vaccine preventable infectious diseases were
obtained for data analysis: diphtheria; haemophilus influenza invasive (note: only Type B
is vaccine preventable); meningococcal disease, invasive; mumps; pertussis, and
poliomyelitis. There was no data on diphtheria and poliomyelitis. I used haemophilus
influenza, invasive meningococcal disease, mumps, and pertussis as Category II
Infectious Diseases.
Originally, the required fields for Research Question 3 were chosen from the
WVEDSS user guide. However, the WV state epidemiology office changed the required
fields to the following based on their required fields: patient unique identifier, date of
diagnosis (and date of laboratory report), date of report to public health (also known as
PHC add time), date of birth, gender, county, state, date of symptom onset, vaccination
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history (which can mean number of doses or date of vaccination), specimen source (if
specimen submission is required), and the date of specimen collection (if specimen
submission is required). The data was cleaned by the WV state epidemiology office and
summarized by the researcher before leaving the WV state epidemiology office. Power
analysis was performed for meningococcal disease and mumps to ensure sufficient
sample size was obtained (p. 107).
Descriptive Statistics of the Sample
The sample included all individuals within both data sets for the entire population
of West Virginia. The sample was representative of all counties and regions of West
Virginia. Therefore the sample was representative of the population of the state of West
Virginia.
Table 4 details the frequency of cases by vaccine preventable infectious disease
(VPID), including valid cases and missing or invalid cases for WVEDSS (2009-2011)
and WVEDSS-NBS (2012-2013). The majority of cases were pertussis, followed by H.
influenza, meningococcal disease, and mumps.
Table 4
Frequency of cases by vaccine preventable disease (n = 714)
Vaccine
Preventable
Infectious
Diseases

Valid cases
2009-2011

H. influenza

101

RQ1 & RQ2
Missing or
Valid cases
invalid
2012-2013
cases
2009-2011
21

92

Missing or
invalid
cases
2012-2013
0

RQ3
All available All
cases
available
2009-2011
cases
2012-2013
122

92

82
meningococcal
disease

20

3

9

0

23

9

8

0

6

0

8

6

288

45

116

5

333

121

417

69

223

5

486

228

mumps
pertussis
Total cases

Table 5 details the geographic description of cases by vaccine preventable
infectious disease (VPID), including cases by Region for WVEDSS (2009-2011) and
WVEDSS-NBS (2012-2013). The state is divided up into regions geographically and
each region is assigned to a Regional Epidemiologist who oversees these areas. The
majority of cases were in Region 2, 3, 5 and 7.
Table 5
Geographic description of cases by region (n = 905)
Vaccine
Preventable
Infectious
Diseases
H. influenza
2009-2011
2012-2013
meningococcal
disease
2009-2011
2012-2013
mumps
2009-2011
2012-2013
pertussis
2009-2011
2012-2103
Total Cases

1

Regions
4

2

3

5

6

7

8

21
12

27
15

22
28

11
10

13
6

9
5

7
7

12
6

1
0

3
0

2
4

5
0

4
1

2
1

5
1

1
2

0
1

2
1

3
0

0
0

0
0

2
2

1
2

0
0

29
32

17
14

41
29

35
14

126
14

12
3

46
5

27
6

96

178

147

75

164

54

128

63
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Results
Research Question 1
An independent-samples, t test was run to determine if there were differences in
mean reporting times between 101 H. influenza WVEDSS cases and 92 WVEDSS-NBS
H. Influenza cases. The mean reporting times (days) were shorter for WVEDSS H.
Influenza cases (M = 5.19, S.D. = 5.72) than for WVEDSS-NBS H. Influenza cases (M =
17.22, S.D. = 19.43). The assumption of homogeneity of variances was violated, as
assessed by Levene’s test for equality of variances (p < .001). Equal variances were not
assumed and there was a statistically significant difference in mean reporting times for H.
influenza between WVEDSS and WVEDSS-NBS, t (105.338) = 5.716, p < .05.
Therefore, we can reject the null hypothesis and accept the alternative hypothesis.
An independent-samples, t test was run to determine if there were differences in
mean reporting times between 20 meningococcal disease WVEDSS cases and 9
WVEDSS-NBS meningococcal disease cases. The mean reporting times were shorter for
WVEDSS meningococcal disease cases (M = 1.55, S.D. = 2.44) than for WVEDSS-NBS
meningococcal disease cases (M = 8.00, S.D. = 6.97). The assumption of homogeneity of
variances was violated, as assessed by Levene’s test for equality of variances (p < .001).
Equal variances were not assumed and there was a statistically significant difference in
mean reporting times for meningococcal disease between WVEDSS and WVEDSS-NBS,
t (8.895) = 2.705, p = .024. Therefore, we can reject the null hypothesis and accept the
alternative hypothesis.

84
An independent-samples, t test was run to determine if there were differences in
mean reporting times between 8 mumps WVEDSS cases and 6 WVEDSS-NBS mumps
cases. The mean reporting times were shorter for WVEDSS mumps cases (M = 3.88, S.D.
= 2.90) than for WVEDSS-NBS mumps cases (M = 3.83, S.D. = 4.92). There was
homogeneity of variances for mean reporting times for WVEDSS and WVEDSS-NBS, as
assessed by Levene’s test for equality of variances (p = .077). Equal variances were
assumed and there was not a statistically significant difference in mean reporting times
for mumps between WVEDSS and WVEDSS-NBS, t (12) = 0.020, p = 0.99. Therefore,
we can reject the alternative hypothesis and fail to reject the null hypothesis.
An independent-samples, t test was run to determine if there were differences in
mean reporting times between 289 pertussis WVEDSS cases and 116 WVEDSS-NBS
pertussis cases. The mean reporting times were shorter for WVEDSS pertussis cases (M =
5.01, S.D. = 22.05) than for WVEDSS-NBS pertussis cases (M = 26.01, S.D. = 37.44).
The assumption of homogeneity of variances was violated, as assessed by Levene’s test
for equality of variances (p < .001). Equal variances were not assumed and there was a
statistically significant difference in mean reporting times for pertussis between
WVEDSS and WVEDSS-NBS, t (148.096) = 5.659, p < .05. Therefore, we can reject the
null hypothesis and accept the alternative hypothesis.
Table 6 details the mean reporting time (MRT) of cases by vaccine preventable
infectious disease (VPID), including the number of cases before and after the
intervention, t value, dF, and the P values for WVEDSS (2009-2011) and WVEDSS-NBS
(2012-2013). The majority of MRT for WVEDSS cases were shorter then MRT for
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WVEDSS-NBS cases. Meaning that timeliness was better before the intervention of the
Web-based server.

Table 6
Cases by mean reporting time (n = 713)
RQ 1
Vaccine
Preventable
Infectious
Diseases
H. influenza
meningococcal
disease

WVEDSS
Cases
20092011
101

WVEDSS-NBS
Cases
2012-2013

MRT
WVEDSS
09-11

92

20

9

8

6

289

116

M=5.19,
S.D.=5.72
M=1.55,
S.D.=2.44
M=3.88,
S.D.=2.90
M=5.01,
S.D.=22.05

mumps
pertussis

MRT
t value dF
P
WVEDSSvalu
NBS
e
12-13
M=17.22,
5.716 105.338 < .05
S.D.=19.43
M=8.00,
2.705 8.895
.024
S.D.=6.97
M=3.83,
0.020 12
0.99
S.D.=4.92
M=26.01,
5.659 148.096 < .05
S.D.=37.44

Research Question 2
An independent-samples, t test was run to determine if there were differences in
24-hour standard reporting times between 101 H. influenza WVEDSS cases and 92
WVEDSS-NBS H. influenza cases. The 24-hour standard reporting times were shorter
for WVEDSS H. influenza cases (M = 1.65, S.D. = 0.48) than for WVEDSS-NBS H.
influenza cases (M = 1.96, S.D. = 0.21). The assumption of homogeneity of variances
was violated, as assessed by Levene’s test for equality of variances (p < .001). Equal
variances were not assumed and there was a statistically significant difference in mean
reporting times for H. influenza between WVEDSS and WVEDSS-NBS, t (138.249) =
5.809, p < .05. Therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
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Independent-samples, t test was run to determine if there were differences in 24hour standard reporting times between 20 meningococcal disease WVEDSS cases and 9
WVEDSS-NBS meningococcal disease cases. The 24-hour standard reporting times were
shorter for WVEDSS meningococcal disease cases (M = 1.35, S.D. = 0.48) than for
WVEDSS-NBS meningococcal disease cases (M = 2.00, S.D. = 0). The assumption of
homogeneity of variances was violated, as assessed by Levene’s test for equality of
variances (p < .001). Equal variances were not assumed and there was a statistically
significant difference in the 24-hour standard reporting times for meningococcal disease
between WVEDSS and WVEDSS-NBS, t (19.000) = 5.940, p < .05. Therefore, we can
reject the null hypothesis and accept the alternative hypothesis.
Independent-samples, t test was run to determine if there were differences in 24hour standard reporting times between 8 mumps WVEDSS cases and 6 WVEDSS-NBS
mumps cases. The 24-hour standard reporting times were shorter for WVEDSS mumps
cases (M = 1.88, S.D. = 0.35) than for WVEDSS-NBS mumps cases (M =1.50, S.D. =
0.55). The assumption of homogeneity of variances was violated, as assessed by
Levene’s test for equality of variances (p = .024). Equal variances were not assumed and
there was a statistically significant difference in the 24-hour standard reporting times for
mumps between WVEDSS and WVEDSS-NBS, t (8.052) = 1.464, p = .181. Therefore,
we can reject the null hypothesis and accept the alternative hypothesis.
Independent-samples, t test was run to determine if there were differences in 24hour standard reporting times between 288 pertussis WVEDSS cases and 116 WVEDSSNBS pertussis cases. The 24-hour standard reporting times were shorter for WVEDSS
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pertussis cases (M = 1.52, S.D. = 0.50) than for WVEDSS-NBS pertussis cases (M =
1.88, S.D. = 0.33). The assumption of homogeneity of variances was violated, as assessed
by Levene’s test for equality of variances (p < .001). Equal variances were not assumed
and there was a statistically significant difference in the 24-hour standard reporting times
for pertussis between WVEDSS and WVEDSS-NBS, t (319.902) = 8.387, p < .05.
Therefore, we can reject the null hypothesis and accept the alternative hypothesis.
Table 7 details the 24-hour standard reporting time of cases by vaccine
preventable infectious disease (VPID), including the number of cases before and after the
intervention, t value, dF, and the P values for WVEDSS (2009-2011) and WVEDSS-NBS
(2012-2013). None of the cases before or after the intervention meet the 24-hour standard
reporting times for Category II Infectious Diseases. In fact, the times actually increased
after the intervention of the Web-based server.

Table 7
Cases by 24-hour standard reporting time (n = 712)
RQ 2
Vaccine
Preventable
Infectious
Diseases

WVEDSS
Cases
2009-2011

WVEDSS-NBS
Cases
2012-2013

24-hour
standard
WVEDSS
09-11

H. influenza

101

92

meningococcal
disease

20

9

8

6

288

116

M=1.65,
S.D.=0.48
M=1.35,
S.D.=0.48
M=1.88,
S.D.=0.35
M=1.52,
S.D.=0.50

mumps
pertussis

24-hour
standard
WVEDSSNBS
12-13
M=1.96,
S.D.=0.21
M=2.00,
S.D.=0.00
M=1.50,
S.D.=0.55
M=1.88,
S.D.=0.33

t value dF

P value

5.809

138.249

< .05

5.940

19.000

< .05

1.464

8.052

.181

8.387

319.902

< .05
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Research Question 3
An independent-samples, t test was run to determine if there were differences in
Incomplete Fields/Complete Fields Ratio between 122 H. influenza WVEDSS cases and
92 WVEDSS-NBS H. influenza cases. The Incomplete/Complete Ratio was less
complete for WVEDSS H. influenza cases (M = 0.32, S.D. = 0.24) than for WVEDSSNBS H. influenza cases (M = 0.07, S.D. = 0.07). The assumption of homogeneity of
variances was violated, as assessed by Levene’s test for equality of variances (p < .001).
Equal variances were not assumed and there was a statistically significant difference in
the Incomplete to Complete Ratio for H. influenza between WVEDSS and WVEDSSNBS, t (147.088) = 11.221, p < .05. Therefore, we can reject the null hypothesis and
accept the alternative hypothesis.
Independent-samples, t test was run to determine if there were differences in
Incomplete Fields/Complete Fields Ratio between 20 meningococcal disease WVEDSS
cases and 9 WVEDSS-NBS meningococcal disease cases. The Incomplete/Complete
Ratio was less complete for WVEDSS meningococcal disease cases (M = 0.22, S.D. =
0.05) than for WVEDSS-NBS meningococcal disease cases (M = 0.02, S.D. = 0.07).
There was homogeneity of variances for the 24-hour standard reporting time for
WVEDSS and WVEDSS-NBS, as assessed by Levene’s test for equality of variances (p
= .228). Equal variances were assumed and there was not a statistically significant
difference in the Incomplete to Complete Ratio for meningococcal disease between
WVEDSS and WVEDSS-NBS, t (30) = 8.668, p > .05. Therefore, we can reject the
alternative hypothesis and fail to reject the null hypothesis.
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Independent-samples, t test was run to determine if there were differences in
Incomplete Fields/Complete Fields Ratio between 8 mumps WVEDSS cases and 6
WVEDSS-NBS mumps cases. The Incomplete/Complete Ratio is less complete for
WVEDSS mumps cases (M = 0.13, S.D. = 0.57) than for WVEDSS-NBS mumps cases
(M = 0.10, S.D. = 0.00). The assumption of homogeneity of variances was violated, as
assessed by Levene’s test for equality of variances (p = .002). Equal variances were not
assumed and there was a statistically significant difference in the Incomplete to Complete
Ratio for mumps between WVEDSS and WVEDSS-NBS, t (7.000) = 1.528, p = .170.
Therefore, we can reject the null hypothesis and accept the alternative hypothesis.
Independent-samples, t test was run to determine if there were differences in
Incomplete Fields/Complete Fields Ratio between 333 pertussis WVEDSS cases and 121
WVEDSS-NBS pertussis cases. The Incomplete/Complete Ratio was less complete for
WVEDSS pertussis cases (M = 0.26. S.D. = 0.11) than for WVEDSS-NBS pertussis cases
(M = 0.03, S.D. = 0.08). The assumption of homogeneity of variances was violated, as
assessed by Levene’s test for equality of variances (p = .001). Equal variances were not
assumed and there was a statistically significant difference in the Incomplete to Complete
Ratio for pertussis between WVEDSS and WVEDSS-NBS, t (284.892) = 24.544, p < .05.
Therefore, we can reject the null hypothesis and accept the alternative hypothesis.
Table 8 details the completeness (incomplete/complete) of cases by vaccine
preventable infectious disease (VPID), including the number of cases before and after the
intervention, t value, dF, and the P values for WVEDSS (2009-2011) and WVEDSS-NBS
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(2012-2013). All WVEDSS-NBS cases were less complete after the intervention of the
Web-based server.
Table 8
Cases by completeness ratio (n = 712)
RQ 3
Vaccine
Preventable
Infectious
Diseases

WVEDSS
Cases
20092011

WVEDSSNBS
Cases
2012-2013

24-hour
standard
WVEDSS
09-11

H. influenza

122

92

meningococcal
disease

20

9

8

6

333

121

M=0.32,
S.D.=0.24
M=0.22,
S.D.=0.05
M=0.13,
S.D.=0.57
M=0.26,
S.D.=0.11

mumps
pertussis

24-hour
standard
WVEDSSNBS
12-13
M=0.07,
S.D.=0.07
M=0.02,
S.D.=0.07
M=0.10,
S.D.=0.00
M=0.03,
S.D.=0.08

t value

dF

P
valu
e

11.221

147.088

<
.05

8.668

30

1.528

7.000

<
.05

24.544

284.892

.170
<
.05

Summary
There was a statistically significant difference between means (p < .05) for all
research questions and vaccine preventable infectious diseases except for mumps mean
reporting time for Research Question 1. For this question, there was not a statistically
significant difference between means (p > .05), and therefore, we fail to reject the null
hypothesis. For research question 1, all the vaccine preventable diseases mean reporting
times were longer after the intervention. There was a statistically significant difference
between means (p < .05) for all research questions and vaccine preventable infectious
diseases except for mumps mean reporting time for Research Question 2. For research
question 2, three vaccine preventable infectious diseases were longer after the
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intervention and mumps were longer before the intervention. There was a statistically
significant difference between means (p < .05) for all research questions and vaccine
preventable infectious diseases except for meningococcal disease for Research Question
3. Therefore, for meningococcal disease we can reject the alternative hypothesis and fail
to reject the null hypothesis. All the vaccine preventable diseases for Research Question 3
were less complete after intervention.
1. Is there a difference in mean reporting time of Category II reportable infectious
diseases between the two data systems (WVEDSS and WVEDSS-NBS) in West
Virginia?
a. H. influenza
There was a statistically significant difference between means (p <
.05), and therefore, we can reject the null hypothesis and accept the
alternative hypothesis.
b. meningococcal disease
There was a statistically significant difference between means (p <
.05), and therefore, we can reject the null hypothesis and accept the
alternative hypothesis.
c. mumps
There was not a statistically significant difference between means (p > .05),
and therefore, we can reject the alternative hypothesis and fail to reject the
null hypothesis.
d. pertussis
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There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
2. Is there a difference from the 24-hour standard (time delay) of the infectious diseases
under Category II of the West Virginia reportable infectious diseases for both data
sources?
a. H. influenza
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
b. meningococcal disease
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
c. mumps
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
d. pertussis
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
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3. Are the required fields (identifier, dob, gender, state, county, reporting facility
identifier, program area, jurisdiction, date received by public health, specimen source,
date specimen collected, resulted test, organism, add test result button) complete for
both data sources?
a. H. influenza
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
b. meningococcal disease
There was not a statistically significant difference between means (p > .05),
and therefore, we can reject the alternative hypothesis and fail to reject the
null hypothesis.
c. mumps
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
d. pertussis
There was a statistically significant difference between means (p < .05),
and therefore, we can reject the null hypothesis and accept the alternative
hypothesis.
Chapter 5 will discuss the interpretations, limitations, recommendations, and
implications of these findings.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to pinpoint crucial steps in the surveillance process
from disease diagnosis to disease prevention (regional epidemiologists report to state
epidemiology office) to improve the evaluation of the timeliness and completeness of the
surveillance system. A quasi-experimental, interrupted time-series design, with nonrandom assignment of groups was used to compare the infectious disease cases that were
manually entered into WVEDSS between 2009 and 2012 and those that were entered into
the newly developed WVEDSS-NBS, which was established on Web-based server in
March 2012. In this study, data were collected from March 2012 through December
2013. Timeliness was assessed by the difference in mean reporting times (Report date –
Diagnosis Date) and the 24-hour standard reporting time (Report date – Diagnosis date ≤
1), using the two independent samples t test. The required fields (patient unique
identifier, date of diagnosis, and date of laboratory report), date of report to public health
(also known as PHC add time), date of birth, gender, county, state, date of symptom
onset, vaccination history (which can mean number of doses or date of vaccination),
specimen source (if specimen submission is required), and the date of specimen
collection (if specimen submission is required) were evaluated for completeness by
comparing the incomplete fields/complete fields ratio using the two independent samples
t test. Four Vaccine-Preventable Category II Infectious Diseases were used: H.
influenza, meningococcal disease, mumps, and pertussis.
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Summary of Key Findings
There was a statistically significant difference (p < 0.5) between mean reporting
times of Category II vaccine-preventable infectious diseases between the two data
systems (WVEDSS and WVEDSS-NBS) in West Virginia. The study rejected the null
hypothesis and accepted the alternative hypothesis for H. influenza, meningococcal
disease, and pertussis. For mumps we failed to reject the null hypothesis. There was a
difference from the 24-hour standard of the vaccine preventable infectious diseases under
Category II VPID of the West Virginia reportable infectious diseases for both data
sources. We rejected the null hypothesis and accepted the alternative hypothesis for H.
Influenza, meningococcal disease, mumps, and pertussis. The required fields were
complete for both data sources. We rejected the null hypothesis and accepted the
alternative hypothesis for H. influenza, mumps, and pertussis. The study failed to reject
the null hypothesis for meningococcal disease.
Interpretation of the Findings
The findings disconfirm that timeliness of reporting to the public health
department would improve after the intervention. The mean reporting time for all
infectious diseases increased after the intervention and in some cases the mean reporting
times doubled and tripled. The majority of cases from both datasets did not meet the 24hour standard for reporting Category II infectious diseases. This indicates that the cases
from before and after the intervention were not timely.
These findings confirm that the ratio of incomplete to complete fields improved
after the intervention of a Web-based server. All fields were found to be less complete
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after the intervention. This means that the completeness improved after switching to the
Web-based server, WVEDSS-NBS, in March of 2012.
This data extends knowledge in the discipline. which is illustrated by comparing
the data with what was found in the peer-reviewed literature described in Chapter 2.
Heisey-Grove et al. (2011) agreed that the conventional system was always incomplete
especially in the area of vital risk prevention data fields. Doyle et al.(2002) stated that
active surveillance has proven to have a more complete case record than passive
surveillance. According to Sickbert-Bennett et al. (2011) disease completeness varied not
only by disease in their retrospective cohort study but also by healthcare system. In a
study performed by Effler et al. (1999) they found the electronic format to be far superior
to the conventional paper or manual format. However, the results of this study indicate
that both data systems had complete reporting with data being more complete after the
intervention.
Timeliness is a key element and should be used as a consistent evaluation and
measurement tool of surveillance systems (Yoo et al., 2009). Jajosky and Groseclose
(2004) stated that timeliness is a quantitative indicator of the surveillance systems
reliability and validity and is used to determine any time delays between operational
phases. Reijn et al. (2011) stated that infectious disease surveillance systems (IDSS)
should be regularly evaluated for each step in the system for each disease within the
system. The WV state epidemiology office can use the data from this study on timeliness
to evaluate where the time lag exists in the process from disease diagnosis to disease
reporting.
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Reijn et al. found that the proportion of infectious diseases reported to the LHD
varied by disease. Lazarus et al. (2009) stated that despite all of the improvements made
in surveillance systems across the country some important internal mechanisms still
depend on people. Even though we have come a long way and improved several
qualitative and quantitative aspects of infectious disease reporting training and integrating
primary stakeholders within the system remains essential. Nicolay et al. (2010) stated that
research has proven that implementation of electronic reporting will decrease timeliness
and increase the completeness of surveillance statistics. The literature and the results of
this study indicate that implementing electronic reporting may not be the reason that the
reporting for vaccine preventable infectious diseases was not timely. An error may be
occurring on the human side of the reporting process.
Incorporating an electronic evaluation system for WVEDSS-NBS can help
epidemiologists’ evaluate the system for timeliness. Madoff, Fisman, and Kass-Hout
(2011) concluded that incorporating the Internet into surveillance reporting would
improve timeliness, sensitivity, and completeness of surveillance system data.
Computerized technology allows for the assessment of timeliness to be completed
routinely on each step in the public health surveillance system. Although completeness
improved in this study timeliness of the system for Category II VPID was longer after the
intervention.
Electronic reporting, electronic health records, and electronic laboratory reporting
have the potential to improve all system attributes. Wurtz and Cameron (2005) illustrated
that despite these obvious improvements in infectious disease surveillance, physicians
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must still do their part in submitting a comprehensive and well-timed case report. When
analyzing the data it was discovered that although the completeness of
incomplete/complete fields improved after the intervention timeliness actually increased.
One reason for this may have been that the actually intervention, going to a Web-based
server, may not have been communicated to the stakeholders. The physicians and other
health professionals that diagnose patients and record the diagnosis date may not have
been aware that a change was taken place in reporting. A qualitative study surveying this
group of stakeholders could be done in the future to examine this line of reasoning.
On the other side, the WV state epidemiologist office assigns epidemiologists to
specific regions in the state. The response of these individuals on a questionnaire for
report date fields may shed some light on the increased timeliness for infectious diseases
in Category II. These regional epidemiologists are the leading innovators and adopters in
their field. The process of diffusion is first identified as an informal planning process that
is followed by a formal structured procedure driven by social networking within the
organization.
It may be that during the implementation of the WVEDSS-NBS the technological
difficulties surpassed the epidemiologist’s ability to report cases to the state office in a
timely manner. Perhaps a more formal process of dissemination should have been
implemented so that essential stakeholders were prepared for implementing data on time.
Researchers contesting the paradigms of diffusion research have illustrated that those
new technologies previously integrated using only simple diffusion should have gone
through a more formal dissemination process (Greenhalgh et al., 2004). For instance,
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Rogers (2003) suggested using the technology cluster model for technological
innovations that include more than one technology within the system. The WV state
epidemiology office will need to consider all aspects of the innovation and coordinate a
strategy for implementation that includes all the stakeholders in the system.
One area that was not covered in this study was the time from disease onset to
diagnosis. Yoo et al. (2009) stated that timely reporting is effected most by the interval
from disease inception to diagnosis. As electronic disease reporting improves the
evaluation of this step in the surveillance process can be incorporated into the
surveillance process. Yoo et al. (2009) stated that previous research has indicated that the
surveillance steps of infectious disease reporting vary from system to system and from
one infectious disease to another. In this study all Category II VPID were measured for
timeliness in the same manner.
The most important aspect in evaluating the timeliness of a surveillance system is
to establish a standard definition. Timeliness was defined in terms of mean reporting time
and the 24-hour standard. Jajosky and Groseclose (2004) collected data on the National
Notifiable Disease Surveillance System (NNDSS) and suggested using the earliest known
date of disease onset as the starting point for the measurement of timeliness, varying by
disease. The comparison of timeliness from paper to a Web-based server illustrated key
factors causing delays in the timely reporting of infectious diseases. These key factors
may assist epidemiologists in improving the timeliness of the WVEDSS-NBS.
Results of the Colorado Electronic Disease Reporting System (CEDRS) prompted
training of disease investigators to fill out intake forms completely with the hope that
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future evaluations will yield improved timeliness and more complete data. Vogt, Spittle,
Cronquist, and Patnaik (2006) illustrated how a LHD could evaluate the CEDRS for
timeliness and completeness. Timeliness was defined as the time period between
“specimen collection date” and “report date” for each patient and they compared them
through distribution of means. In this study I did not have a problem with the
completeness of the “diagnosis date” or “report date”. However, when the WV State
Epidemiologist Office may run into problems here when they evaluate the entire
surveillance system to establish their baseline.
Some of the most common reasons for delayed reporting are patient’s recognition
of symptoms, communication issues, missing data, incorrect data, disease specific
incubation periods, and laboratory-related delays. Reijn et al. (2011) illustrated that
electronic laboratory reporting (ELR) has improved the timeliness in some nations and
concluded that an international standardization method for measuring timeliness be
supported. The WVEDSS-NBS has not implemented ELR within its system. The results
indicated that some fields had incorrect data and missing data, which may be resolved by
instilling a warning message within the data entry feature.
The evaluation of data from surveillance systems for timeliness varies because
each study examines different diseases and measures of timeliness. Yoo et al. (2009)
evaluated over 40,000 infectious disease records from an electronic system that collected
data in 2000. They found that the greatest time delay stemmed from the delay in
diagnosis from the clinical side and from the excess time spent on lengthy laboratory
tests. They found that the total time from disease onset to reporting to the local health
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department ranged from six to twenty days and varied from one disease to another. In this
study the total time from disease onset to reporting to the state health department ranged
from one to 366 days.
Most studies found that electronic reporting resulted in an improvement in all
system attributes especially timeliness. Effler et al. (1999) compared an electronic
reporting system to the previous conventional system and found a 2.3 fold increase in
infectious disease reporting with the new system. The CDC (2005) stated that in New
Jersey, which has a Web-based server like WVEDSS-NBS that they implemented in
2001, the number of cases reported from 2002 to 2004 doubled and that the average days
for case reporting dropped from 28 days in 2002 to 3-4 days in 2004. In this study the
mean reporting times increased after the switch to a Web-based server and the 24-hour
standard reporting times were not met.
Even though most states have adapted to national guidelines by using the NEDSS
equivalent software to upgrade their paper based systems to electronic or Web-based
servers many problems still exist in establishing standards for information exchange. As
the interface between clinicians and public health officials improve the data becomes
more streamlined and universal. In the past health data was faxed, mailed, or emailed to
the local or regional epidemiologist to be entered into the state system. The
epidemiologist entered this data into the system sometimes weeks after the information
had been received or the notifiable condition had transpired. The CDC (2005) reported
that many (10-85%) of these cases never made it to the national level and previously
states used over 100 different systems to send reports to the CDC. A review of the
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literature has revealed that many definitions and standards of measurement for timeliness
have been used in the past. I used the CDC’s recommendations for the measurement for
timeliness and the incomplete/complete ratio for the completeness to prepare a
foundation for future measurements on WVEDSS-NBS. West Virginia may find that they
need to implement ELR to improve the timeliness of WVEDSS-NBS.
Electronic disease reporting has become the standard by which all other reporting
is to be compared. According to several researchers (Reijn et al., 2011; Yoo et al., 2009;
Nicolay et al., 2010; Doyle et al., 2002) electronic disease reporting has improved the
timeliness of infectious disease outbreak notification. In addition these authors and the
CDC (2005) recommend that states integrate ELR into their existing systems to improve
timeliness because laboratory tests are used to confirm most infectious diseases, labs are
important members of the system, and laboratories can be used for other aspects of public
health surveillance.
As West Virginia learns more about electronic disease reporting process and
builds the state surveillance infrastructure to comply with national standards, the
evaluation process will improve. Nicolay et al. (2010) stated that research has proven that
implementation of electronic reporting will decrease timeliness and increase the
completeness of surveillance statistics. Electronic data and evaluation methods at the
local, state, national, and international level allows for more complete assessment of
infectious diseases and their spread around the globe.
Completeness was measured by the ratio of incomplete fields to complete fields
of data items required by the West Virginia state epidemiology office. According to
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Doyle et al. (2002) infectious disease reporting completeness identifies those notifiable
cases that have been reported to the local health department. The completeness of intake
forms is crucial to the proper accounting of cases of infectious disease within a
population. Without this vital information to guide the epidemiologist and other public
health officials in the diagnosis of notifiable infectious diseases, outbreaks may be missed
and epidemics may occur. Although this study indicated an improvement in
completeness overall there is room for WVEDSS-NBS completeness to improve.
It is important to evaluate infectious disease completeness by each disease under a
specific Category. Jajosky and Groseclose (2004) stated that mandatory infectious
disease reporting in the U.S. varies from 9% to 99% and that active surveillance
completeness was much better than passive disease surveillance systems completeness.
The NEDSS has outlined standards for the evaluation of surveillance systems to improve
the accuracy, completeness, and timeliness of infectious disease reporting in the United
States. I evaluated disease completeness by assessing the ratio of incomplete to complete
fields by each infectious disease under a specific Category on both datasets intake forms.
The NEDSS recommends that each state follow guidelines for submitting
infectious disease data. Clinicians in West Virginia may need training on the new format
of infectious disease reporting in order to improve timeliness and completeness.
Clinicians outreach programs are essential according to Lazarus et al. (2009) because
despite considerable progress in electronic reporting many significant surveillance
procedures still rely on practitioner’s manual entry and submission of data. Training
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health professionals on WVEDSS-NBS and other aspects of electronic disease reporting
can improve the timeliness and completeness of the system.
In the past the measurement and evaluation of disease completeness was a
difficult task. Doyle et al. (2002) explained reasons from the literature for incomplete
infectious disease reporting in the past. The reasons included safety and privacy issues,
misinterpretation of the law regarding notifiable conditions, ignorance of required
infectious disease to report, clueless about where and to whom to report, and inadequate
punishment for not reporting. Even at the national level the evaluation of the NEDSS is
incomplete. According to Sickbert-Bennett et al. (2011) the evaluation of the NEDSS in
the United States is inadequate and previous studies differ on their assessment of
reporting completeness. I evaluated disease completeness in this study using the
incomplete/complete data fields across diseases in Category II VPID. Doyle et al. (2002)
illustrated that the complete integration of all systems as one automated systems is the
future of surveillance systems, ELR, and the EHR. The NEDSS and the CDC are
restructuring the clinical system and public health systems into one complete health
system in the United States. West Virginia has begun infrastructure building and that type
of work does not happen over night.
Limitations of the Study
Permission was obtained to use all the cases under Category II Vaccine
Preventable Infectious Diseases from the state of West Virginia epidemiology office.
This eliminated the limitation from using data from two different time periods, sample
data and reduced selection bias, statistical analysis and Levene’s test also helped in
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controlling for bias, maturation effects, and regression to the mean. Regression to the
mean and maturation are both threats to internal validity and possibilities in this study.
Regression to the mean is a possible threat because the intervention may or not be the
reason for an improvement in surveillance. Maturation effects are a possible threat in
concluding that the intervention caused an improvement in reporting.
Power analysis was conducted to ensure that the sample size from available
secondary data met a minimum level of 95%. The following parameters were included in
G*Power 3.1.7 (Faul, Erdfelder, Lang, & Buchner, 2007; Faul, Erdfelder, Buchner, &
Lang, 2009): Test family (Exact), Statistical test (Inequality, two independent groups
(Fisher’s exact test), Type of power analysis (A priori: Compute required sample size),
two tails, proportions dataset 1 (WVEDSS) = x1, proportion dataset 2 (WVEDSS-NBS)
= x2, α = 0.05, Power (1- β err problem) = 0.95, and allocation ratio (N1/N2) = 2. The
proportion sizes (x1, x2) were determined from the West Virginia DHHR website on
infectious disease surveillance cases from 2007-2014. The following outputs were
determined: sample size haemophilus influenza invasive 1 = 12, group 2 = 24, total
sample size = 36; sample size meningococcal disease group 1 = 1, group 2 = 3, total
sample size = 4; sample size mumps group 1 = 3, group 2 = 5, total sample size = 8;
sample size pertussis group 1 = 21, group 2 = 41, total sample size = 62. Based on these
calculations from G*Power 3.1.7 the sample size was efficient for all VPID.
Recommendations
Recommendations for further research are grounded in the strengths and
limitations of the current study as well as the literature reviewed in chapter 2.
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Recommendations for further research are based on the results of this study. A formal
process for including stakeholders and healthcare professionals should be implemented to
ensure proper adherence to infectious disease reporting. A survey of these individuals and
the regional epidemiologists may shed light into why the timeliness of vaccine
preventable infectious diseases actually increased after the intervention.
Recommendations for action are based on the results of this study and the
literature. An evaluation of all infectious diseases in all categories should be performed to
better understand the timeliness and completeness of the intervention. Electronic
reminders should be sent to regional epidemiologists and healthcare professionals to
reinforce timely reporting according to categories. A plan for action may include
updating the WVEDSS-NBS to the next level, the National Electronic Disease
Surveillance System (NEDSS) To do so, the WV Department of Health and Human
Services would need to incorporate ELR into its current surveillance system. Another
plan of action is to introduce community awareness programs that will engage the health
professionals in the system.
Areas identified for improvement in regard to the diffusion of innovation theory
were identified at the macro level of organization. At the micro level the WV state
epidemiology office’s level of communication and social networking were well
organized. However, areas in dissemination at the macro level to public health officials
and healthcare professionals throughout the state needs to be refined and reworked.
Areas they need to address are stakeholder communication, social networking, and
implementation of Rogers (2003) technology cluster model for technology innovations.
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A SWOT analysis (Attaway, Jacobsen, Falconer, Manca, & Waters, 2014) of the tasks
needed for a macro level dissemination would identify their current strengths,
weaknesses, opportunities, and threats (SWOT) and all potential improvements that need
to be made. Furthermore, incorporating Geographical Information Systems (GIS)
(Busgeeth, 2004 & Ruiz, Tedesco, & McTighe, 2004) into outbreak management would
allow visualization of the data to aid in policy creation and outbreak preparedness.
Implications
The results of this study provide health departments with the information and
tools to address the fundamental factors that help public health officials assess the
population’s health. Integration of the EHR with WVEDSS-NBS allows health
professionals to have instant access to the most recent health data allowing local health
departments to effect social change. We want to reduce morbidity/mortality and one way
to do that is through improving reporting times so that we can better control disease
outbreaks. Therefore we need timely and complete forms to work appropriately. Colbert
and Harrison (2011) stated that to accomplish these tasks more complete epidemiological
and surveillance data must be acquired to understand the complex matrix of health
disparities. A more complete evaluation of surveillance system data needs done by West
Virginia to identify the incidence of Category II infectious diseases and assess the
effectiveness of the LHD by examining, comparing, and evaluating the old WVEDSS and
the newly developed WVEDSS-NBS for these system attributes (identified as timeliness
and completeness). I examined the environment in which the surveillance systems
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operated (by utilizing the diffusion of innovation theory) in order to identify areas for
improvement and sustain social change.
Implications for social change begin at the individual level when one adopter
understands that their actions can bring about the changes needed. It takes one
epidemiologist to see that decreasing the timeliness of WVEDSS-NBS can save money
and improved reporting can reduce the length of outbreaks. The decreased spread of
infectious diseases in the state will reduce mortality and morbidity from disease
outbreaks. Community awareness programs and academic research in the area of timely
reporting can influence policies to improve the timeliness of reporting. The medical
culture and society in West Virginia would be enriched by a more reliable and valid
approach to infectious disease reporting in the state.
Conclusion
The results of the study indicate that the timeliness was quite poor with Category
II VPID. However, the completeness improved after the introduction of the Web-based
server. When implementing an electronic intervention, like a Web-based server, it is
essential to build a communication network to support electronic disease surveillance.
According to Watkins et al. (2009) system attributes for measuring the sensitivity of a
surveillance system should include timeliness, completeness, and the geographic and
demographic data of the population. On going evaluation methods will need to be
implemented by the State of West Virginia to ensure that timeliness and completeness of
surveillance system data improves over time. Healthcare professionals in the state can
utilize the results of this research to improve the system attributes of timeliness and
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completeness. Implications for positive social change included improved access to public
health data to better understand health disparities, which could reduce morbidity and
mortality within the population.
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